hydroxychloroquine and zithromax

hydroxychloroquine has been researched along with zithromax in 421 studies

Research

Studies (421)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (0.48)	29.6817
2010's	5 (1.19)	24.3611
2020's	414 (98.34)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y	1
Basque, J; Cantin, AM; Leduc, R; Martel, M	1
Bush, A; Fitch, JA; Hayes, D; Lloyd, EA	1
Arıkan-Ayyıldız, Z; Caglayan-Sozmen, S; Couderc, R; Deterding, R; Dishop, MK; Epaud, R; Isık, S; Louha, M; Uzuner, N	1
Breuer, O; Schultz, A	1
Chatziioannidis, I; Gialamprinou, D; Karagianni, P; Mitsiakos, G; Papoulidis, I; Soubasi, V; Tsakalidis, C; Tsanakas, I	1
Ashworth, M; Aurora, P; Barbato, A; Bush, A; Calder, A; Carlens, J; Clement, A; Cunningham, S; Graham, C; Griese, M; Hengst, M; Kammer, B; Kiper, N; Krenke, K; Kronfeld, K; Lange, J; Ley-Zaporozhan, J; MacLean, M; Nicholson, AG; Reu, S; Schwerk, N; Wesselak, T; Wetzke, M	1
Brouqui, P; Chabrière, E; Colson, P; Courjon, J; Doudier, B; Gautret, P; Giordanengo, V; Hoang, VT; Honoré, S; La Scola, B; Lagier, JC; Mailhe, M; Meddeb, L; Parola, P; Raoult, D; Rolain, JM; Tissot Dupont, H; Vieira, VE	1
Berenbaum, F; Duarte-García, A; Graef, ER; Grainger, R; Kim, AHJ; Korsten, P; Liew, JW; Putman, MS; Sattui, SE; Sirotich, E; Sparks, JA; Ugarte-Gil, MF; Webb, K	1
Lisanti, MP; Sargiacomo, C; Sotgia, F	1
Fu, J; Mao, J; Shang, S; Shu, Q; Wang, B; Ye, Q; Zhang, T	1
de Castro, N; Delaugerre, C; Goldwirt, L; Le Goff, J; Mela-Lima, B; Molina, JM; Ponscarme, D	1
Harrington, RA; Poppas, A; Roden, DM; Russo, AM	3
Juurlink, DN	1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM	1
Estes, L; Rivera, C; Stevens, RW	1
Andrikopoulou, M; Aubey, J; Baptiste, C; Bernstein, K; Breslin, N; D'Alton, ME; Friedman, AM; Fuchs, K; Goffman, D; Gyamfi-Bannerman, C; Landau, R; Martinez, R; Miller, R; Moroz, L; Mourad, M; Purisch, S; Ring, L; Rupley, D; Sheen, JJ; Simpson, LL; Sutton, D; Wapner, R; Zork, N	1
Brufsky, A	1
Clerc, A; Gendrot, M; Javelle, E; Pradines, B; Savini, H	1
Berenbaum, F; Duarte-García, A; Graef, ER; Grainger, R; Harrison, C; Kim, AH; Konig, MF; Korsten, P; Liew, JW; Proulx, L; Putman, MS; Richards, DP; Robinson, PC; Sattui, SE; Simard, JF; Sirotich, E; Sparks, JA; Ugarte-Gil, MF; Young, KJ	1
Calado, A; Heldwein, FL	1
Doan, T; Oldenburg, CE	1
Avti, P; Bhattacharyya, A; Dhibar, DP; Kaur, H; Kumar, H; Kumar, S; Mahendru, D; Medhi, B; Prajapat, M; Prakash, A; Sarma, P; Shekhar, N; Singh, A; Singh, R	1
Alqarawi, W; Healey, JS; Krahn, AD; Laksman, Z; MacIntyre, CJ; Roberts, JD; Sapp, JL; Steinberg, C; Tadros, R	1
Corrigan, B; Damle, B; Leaney, J; Vourvahis, M; Wang, E	1
Aajal, A; Ait Brik, A; Ammour, O; Benajiba, C; El Boussadani, B; El Hangouch, J; Oussama, B; Oussama, O; Raissuni, Z; Tahiri, N	1
Chabner, BA	1
Hsueh, PR; Jean, SS; Lee, PI	1
Chan, R; Lipworth, B; Lipworth, S; RuiWen Kuo, C	1
Antunes de Brito, CA; Falcão, MB; Filgueiras Filho, NM; Pamplona de Góes Cavalcanti, L	1
Huang, T; Khaddour, K; Nepomuceno, D; Sikora, A; Tahir, N	1
Abena, PM; Adejumo, P; Bottieau, E; Decloedt, EH; Eholie, SP; Kallay, O; Mills, EJ; Muyembe TamFum, JJ; Nachega, JB; Sam-Agudu, NA; Seydi, M; Suleman, F; Zumla, A	1
Brown, JD; Cicali, B; Henriksen, CH; Sarayani, A	1
Aaron, JG; Arcasoy, S; Aversa, MM; Benvenuto, LJ; Brown, RS; Cohen, DJ; Dadhania, DM; Dove, LM; Dube, GK; Emond, JC; Farr, MA; Husain, SA; Kapur, S; Kodiyanplakkal, RP; Miko, BA; Mohan, S; Pereira, MR; Ratner, LE; Rosenblatt, RE; Samstein, B; Satlin, M; Small, CB; Tsapepas, DS; Uriel, N; Verna, EC; Walsh, TJ	1
Beldner, S; Chang, D; Epstein, LM; Gabriels, J; Goldner, B; Ismail, H; John, R; Mitra, R; Saleh, M; Willner, J	1
Drici, MD; Funck-Brentano, C; Nguyen, LS; Roden, DM; Salem, JE	1
Han, S; Hyun, M; Jin, K; Kim, HA; Kim, Y; Kwon, O; Lee, JY; Paek, JH; Park, WY	1
Yakoub-Agha, I	1
Bhatt, PJ; Narayanan, N; Radbel, J	1
Andreani, J; Boxberger, M; Colson, P; Duflot, I; Jardot, P; La Scola, B; Le Bideau, M; Raoult, D; Rolain, JM; Rolland, C; Wurtz, N	1
Beldner, S; Chang, D; Chinitz, J; Epstein, LM; Gabriels, J; Goldner, B; Ismail, H; John, R; Mahmood, E; Makker, P; Mansoor, A; Mitra, R; Mountantonakis, S; Saleh, M; Skipitaris, N; Soo Kim, B; Willner, J	1
Botta, A; Intson, K; Jawaid, A; Kumar, S; Leung, C; Neckles, R	1
Becker, G; El-Hage, W; Hingray, C; Javelot, H; Meyer, G; Michel, B	1
Felsenstein, S; Hedrich, CM; Herbert, JA; McNamara, PS	1
Adams, D; Attarian, S; Cintas, P; Desguerre, I; Laforet, P; Molon, A; Pereon, Y; Pisella, LI; Salort-Campana, E; Solé, G; Stojkovic, T; Tiffreau, V; Wahbi, K	1
Chen, T; Chen, Y; Ferrari, V; Han, Y; Jagasia, D; Kang, Y; Mui, D; Scherrer-Crosbie, M	1
Genoni, G; Kozel, D; Monzani, A; Pistis, G; Scopinaro, A; Secco, GG	1
Tapia, L	1
Seftel, MD	1
Aouba, A; Baldolli, A; Bergot, E; Geffray, L; Justet, A; Martin-Silva, N; Verdon, R	1
Wong, A	1
Astibia, B; Corona, M; Fortún-Abete, J; García, I; García-Hoz, C; Herrera, P; Jiménez, C; López-Jiménez, J; Marquet, J; Martín-Moro, F; Michael, BM; Piris, M; Rodríguez, E; Sáez, AJ	1
Baden, LR; Morrissey, S; Rubin, EJ	1
Carretero-Barrio, I; Fernandez-Nieto, D; Jimenez-Cauhe, J; Moreno-Garcia Del Real, C; Ortega-Quijano, D; Saceda-Corralo, D; Suarez-Valle, A	1
Derendorf, H	1
Lindner, G; Ochsner, H; Ravioli, S	1
Blog, DS; DeHovitz, J; Dufort, EM; Holtgrave, DR; Hutton, B; Kirkwood, J; Kumar, J; Muse, A; Rosenberg, ES; Tesoriero, J; Udo, T; Weinberg, P; Wilberschied, LA; Zucker, HA	1
Anselmi, E; Cavanna, L; Citterio, C; Codeluppi, M; Stroppa, EM; Toscani, I; Zaffignani, E	1
Chahinian, H; Fantini, J; Yahi, N	3
Al-Kofahi, M; Austin, D; Okour, M	1
Aizer, A; Bar-Cohen, R; Barbhaiya, C; Bernstein, S; Chinitz, LA; Chorin, E; Dai, M; Holmes, D; Jankelson, L; Knotts, R; Kogan, E; Magnani, S; Nadeau-Routhier, C; Park, DS; Shulman, E; Spinelli, M; Stefano, C; Wadhwani, L	1
Thai, TN; Vouri, SM; Winterstein, AG	1
Berwick, S; Gidwani, U; Kessler, A; Lancman, G; Naymagon, L; Troy, K	1
Chaumont, H; Couratier, C; Etienne, P; Lannuzel, A; Roger, PM; Roze, E	1
Acunzo, R; Asensio, E; Saad, EB; Sáenz, LC; Uribe, W	1
Abraham, GM; Andrews, R; Bledsoe, TA; Centor, RM; Etxeandia-Ikobaltzeta, I; Forciea, MA; Haeme, R; Humphrey, LL; Jokela, JA; Kansagara, DL; Marcucci, M; Miller, MC; Obley, AJ; Qaseem, A; Yost, J	1
Aydın, GÇ; Azap, A; Dursun, B; Öztürk, HH; Ürün, Y; Utkan, G; Yazgan, SC; Yekedüz, E	1
Brown, SM; Buckel, WR; Greene, T; Grissom, C; Harris, ES; Johnson, SA; Kumar, N; Leither, LM; Paine, R; Peltan, ID; Srivastava, R; Starr, N; Webb, B	1
Aggarwal, G; Aggarwal, S; Bangalore, S; Henry, BM	1
Connerney, M; Luddington, S; Mamtani, S; Rauf, H; Saini, M; Sattar, Y; Syed, U; Ullah, W; Walfish, A	1
Mégarbane, B; Scherrmann, JM	1
Avogaro, A; Capone, F; Ceccato, D; Cipriani, A; Donato, F; Fioretto, P; Gregori, D; Iliceto, S; Maffei, P; Parolin, M; Pesavento, R; Previato, L; Saller, A; Sarais, C; Vettor, R; Zorzi, A	1
Castrejón-Castrejón, S; Escobar, C; Iniesta, A; Martínez-Cossiani, M; Merino, JL; Rey, JR	1
Alexandre, J; Dolladille, C; Drici, MD; Fenioux, C; Funck-Brentano, C; Mira, JP; Moslehi, JJ; Nguyen, LS; Roden, DM; Salem, JE	1
Gullón, P; Lara, MÁ; López-Alfonso, A; Martín Marino, A; Obispo, B; Pangua, C; Pérez-Pérez, M; Rogado, J; Serrano-Montero, G	1
Alvarez Barco, E; Cotter, A; Doran, P; Feeney, E; Hussain, R; Keane, D; Mallon, P; McCarthy, C; Tinago, W; Wallace, D	1
Alffenaar, JW; Andréjak, C; Bachez, P; Bart, PA; Belilovski, E; Blanc, FX; Borisov, S; Cardoso-Landivar, J; Centis, R; Codecasa, LR; D'Ambrosio, L; Dominguez-Castellano, A; Dourmane, S; Fréchet Jachym, M; Froissart, A; García-García, JM; Giacomet, V; Goletti, D; Grard, S; Gualano, G; Izadifar, A; Le Du, D; Luiza De Souza-Galvão, M; Marín Royo, M; Mazza-Stalder, J; Migliori, GB; Motta, I; Ong, CWM; Palmieri, F; Rivière, F; Rodrigo, T; Sánchez-Montalvá, A; Saporiti, M; Scarpellini, P; Schlemmer, F; Silva, DR; Sotgiu, G; Spanevello, A; Sumarokova, E; Tabernero, E; Tadolini, M; Tambyah, PA; Tiberi, S; Torre, A; Visca, D; Zabaleta Murguiondo, M	1
Risch, HA	2
Albert, CM; Cheng, S; Chugh, H; Chugh, SS; Cingolani, E; Ebinger, J; Marban, E; Park, E; Ramireddy, A; Reinier, K; Thompson, M	1
Bhowmick, S; Das, S; Sen, S; Tiwari, S	1
Benoit, JL; Farley, B; Frohne, C; Hazra, A; McNulty, M; Pettit, N; Pho, M; Pitrak, D; Pursell, K; Ridgway, JP; Saltzman, J; Schmitt, J; Uvin, AZ	1
Bakouny, Z; Batist, G; Bekaii-Saab, T; Bilen, MA; Bouganim, N; Castellano, D; Choueiri, TK; de Lima Lopes, G; Del Prete, SA; Desai, A; Doroshow, DB; Egan, PC; Elkrief, A; Farmakiotis, D; Flora, D; Galsky, MD; Glover, MJ; Griffiths, EA; Grivas, P; Gulati, AP; Gupta, S; Hafez, N; Halfdanarson, TR; Hawley, JE; Hsu, CY; Hsu, E; Kasi, A; Khaki, AR; Kuderer, NM; Larroya, MB; Lemmon, CA; Lewis, C; Logan, B; Lyman, GH; Masters, T; McKay, RR; Mesa, RA; Mishra, S; Morgans, AK; Mulcahy, MF; Painter, CA; Panagiotou, OA; Peddi, P; Pennell, NA; Peters, S; Reynolds, K; Rini, BI; Rivera, DR; Rosen, LR; Rosovsky, R; Rubinstein, SM; Salazar, M; Schmidt, A; Shah, DP; Shah, SA; Shaya, JA; Shete, S; Shyr, Y; Steinharter, J; Stockerl-Goldstein, KE; Subbiah, S; Thompson, MA; Vinh, DC; Warner, JL; Wehbe, FH; Weissmann, LB; Wu, JT; Wulff-Burchfield, E; Xie, Z; Yeh, A; Yu, PP; Zhou, AY; Zubiri, L	1
Frigerio, M	1
Abdul Rani, R; Cheah, WK; Hor, CP; Hussin, N; Jugindar Singh, GPS; Nalliah, S; Ooi, WT; Perumal, K; Tang, XY; Zachariah, S	1
Beverina, A; Calegari, J; Fanin, A; Tiraboschi, S	1
Davutoglu, M; Erden, A; Gemcioglu, E; Ozdemir, EE	1
Akar, JG; Chamoun, R; DelVecchio, A; Howes, C; Hummel, JP; Li, C; Maraj, I; Taoutel, R; Tran, L; Workman, V	1
Aizer, A; Bar-Cohen, R; Barbhaiya, C; Bernstein, S; Chinitz, LA; Chorin, E; Dai, M; Holmes, D; Jankelson, L; Park, DS; Shulman, E; Spinelli, M; Wadhwani, L	1
Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T	1
Dash, AP; Nina, PB	1
Clevenbergh, P; De Bels, D; Leemans, S; Mahadeb, B; Maillart, E; Salaouatchi, MT; Van Noten, H; Vandergraesen, T	1
Campos, L; Gouveia, CC	1
Abdalla, M; Anstey, DE; Fried, JA; Givens, RC; Karmpaliotis, D; Kirtane, AJ; Kodali, SK; Kumaraiah, D; Leon, MB; Masoumi, A; Rabbani, LE; Ranard, LS; Sayer, G; Schwartz, A; Takeda, K; Uriel, N	1
Gullón, P; Lara, MÁ; López-Alfonso, A; Marino, AM; Obispo, B; Pangua, C; Pérez-Pérez, M; Rogado, J; Serrano-Montero, G	1
Chen, FL; Hung, CS; Lee, WS; Su, YS; Wang, CH	1
Danion, F; Fourtage, M; Greigert, V; Hansmann, Y; Kaeuffer, C; Lefebvre, N; Muller, J; Nai, T; Ruch, Y	1
Baptiste, C; Breslin, N; D'Alton, M; Fuchs, K; Goffman, D; Gyamfi-Bannerman, C; Miller, R	1
Alstrup, G; Benfield, TL; Biering-Sørensen, T; Bojesen, RD; Browatzki, A; Brøndum, E; Bødtger, UCS; Eklöf, JV; Ghanizada, M; Gottlieb, V; Håkansson, KEJ; Janner, J; Jensen, JS; Jensen, SG; Knop, FK; Lapperre, TS; Laursen, CB; Lundgren, JD; Madsen, BL; Meteran, H; Moberg, M; Møller, UW; Pedersen, L; Porsbjerg, C; Rasmussen, DB; Sivapalan, P; Sonne, TP; Sverrild, A; Sørensen, SW; Tidemansen, C; Tupper, OD; Ulrik, CS; Wilcke, JT	1
Berni-Betancourt, A; Carrasco, OF; Medeiros-Domingo, A	1
Almond, LM; Ban Ke, A; Jones, HM; Pan, X; Rowland Yeo, K; Wesche, D; Zhang, M	1
Bartoletti, M; Viale, P	1
Scherrmann, JM	2
Wang, SH; Wang, YL; Yang, AY	1
Lauriola, M; Pani, A; Romandini, A; Scaglione, F	1
Aragones-Garcia, M; Bellido, S; Cabrera-Rojo, C; Fernandez-Ferro, J; Guillan, M; Perez-Jorge Peremarch, C; Suarez-Vega, VM; Villacieros-Alvarez, J	1
Medina, MT; Moncada, SS	1
Kadono, Y; Kajikawa, R; Kishima, H; Matsumoto, M; Nakajima, Y; Nakamura, Y; Ogawa, Y; Yamamoto, S	1
Abraham, GM; Etxeandia-Ikobaltzeta, I; Forciea, MA; Humphrey, LL; Jokela, JA; Miller, MC; Obley, AJ; Qaseem, A; Yost, J	1
Alonso Charterina, S; Díaz Campos, R; Fernández Crespo, J; Fernández Rodríguez, C; García-Moguel, I	1
Cavalcanti, DD; Dehkharghani, S; Jain, R; Lillemoe, K; Nelson, PK; Nossek, E; Radmanesh, A; Raz, E; Riina, HA; Shapiro, M; Torres, J; Yaghi, S	1
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N	1
Wu, J	1
Fellahi, JL; Ferraris, A; Hugon-Vallet, E; Jacquet-Lagrèze, M; Riad, Z	1
Alibeyoglu, AM; Cagatay, AA; Demir, E; Dirim, AB; Garayeva, N; Orhun, G; Oto, OA; Safak, S; Turkmen, A; Ucar, AR; Yazici, H	1
Ahn, BY; Choe, PG; Kang, CK; Kim, NJ; Oh, MD; Park, SW; Park, WB; Seo, JD; Song, SH	1
Cham, S; Chen, TY; Farghaly, S; Rauda, R; Ribisi, M; Sin, JH; Sumrani, N; Tatem, LL	1
Ali, NM; Cartiera, K; Labella, P; Leonard, J; Mehta, SA; Montgomery, RA; Neumann, H; Soomro, I	1
Farooqi, J; Jabeen, K; Mahmood, SF; Nasir, N	1
Fueyo-Rodriguez, O; Moreno-Sanchez, F; Palomar-Lever, A; Valente-Acosta, B	1
Baudouy, D; Bun, SS; Courjon, J; Dellamonica, J; Doyen, D; Esnault, V; Ferrari, E; Labbaoui, M; Levraut, J; Marquette, CH; Sartre, B; Scarlatti, D; Squara, F; Taghji, P; Theodore, G	1
Aguado, P; Balsa, A; Bernad-Pineda, M; Bogas, P; Bonilla, G; Castilla-Plaza, A; De Miguel, E; Franco-Gómez, K; García-Lorenzo, E; Miranda-Carus, ME; Monjo, I; Novella Navarro, M; Nuño, L; Peiteado, D; Rodríguez-Araya, T; Tornero, C; Villalba, A	1
Blaufox, AD; Friedman, RA; Ganigara, M; Mitchell, E; Samuel, S; Schleien, C; Sharma, C	1
Martínez-Arboleda, JJ; Parra-Lara, LG; Rosso, F	1
Alangaden, GJ; Arshad, S; Brar, I; Chaudhry, ZS; Huitsing, K; Jacobsen, G; Kilgore, P; McKinnon, JE; O'Neill, W; Ramesh, MS; Wang, DD; Zervos, M	1
Carron, J; Hussein, H; Kennedy, M; McAdam, B; Sharif, Z; Sheahan, R	1
Budnitz, DS; Lovegrove, M; Shehab, N	1
Allison, D; Campbell-Lee, S; Crane, J; Fraidenburg, D; Hussain, F; Vidanovic, V; Webb, S	1
Darrieux, FCDC; Hachul, DT; Melo, SL; Pisani, CF; Sacilotto, L; Scanavacca, M; Wu, TC	1
Bala, J; Balík, M; Beneš, J; Černý, V; Duška, F; Halačová, M; Klementová, O; Kozáková, I; Kubricht, V; Le Roy, A; Řehořová, V; Vymazal, T; Waldauf, P; Zvoníček, V	1
Cauda, R; Cingolani, A; Cipriani, MC; Fantoni, M; Gremese, E; Larosa, L; Liperoti, R; Montemurro, G; Murri, R; Pasciuto, G; Pirronti, T; Tummolo, AM	1
Cipriani, MS; Massabeti, R; Valenti, I	1
Daily, J; Di Biase, L; Ferrick, KJ; Fisher, JD; Greige, N; Hsia, BC; Khokhar, AS; Krumerman, A; Quiroz, JA	1
Allwood, B; Blockman, M; Decloedt, EH; Koegelenberg, CFN; Parker, A; Reuter, H; Taljaard, J	1
Abi Jaoude, J; El Alam, MB; Garcia Garcia, CJ; Kouzy, R; Ludmir, EB; Taniguchi, CM	1
Alvarez, RA; Auerbach, JS; de Marchena, EJ; Delazerda, D; Ghodsizad, A; Grant, AA; Guerra, G; Hare, J; Khalid, L; Loebe, M; Mirsaeidi, M; Sneij, WC; Vianna, R	1
McDonald, R	1
Rosendaal, FR	1
Bleeker-Rovers, CP; Bousema, T; de Mast, Q; Machiels, JD; Rahamat-Langendoen, J; Ten Oever, J; Ter Heine, R; van Crevel, R; Wertheim, HF	1
Alsamarai, S; Chavez, V; Ferrara, L; Hsu, K; Oliva, M	1
Danzi, GB; Di Tano, G; Gherbesi, E; Loffi, M; Moschini, L; Regazzoni, V	1
Carter, BL; Comellas, AP; Polgreen, LA; Polgreen, PM; Simmering, JE; Teske, RE	1
Fazio, N; Funicelli, L; Garcia-Carbonero, R; Gervaso, L; Laffi, A; Pellicori, S; Rubino, M; Spada, F; Zampino, G	1
Çetinkaya, E; Çinarka, H; Çörtük, M; Özgül, MA; Tanriverdİ, E; Turan, D; Uğur Chousein, EG; Yildirim, BZ	1
Fleury, V	1
Costagliola, D; Peiffer-Smadja, N	1
Boga, A; Durmaz, H; Guven, S; Karaci, M; Tuncer, T	1
Bannan, C; Bergin, C; Carr, B; Clarke, S; Coghlan, M; Doyle, C; Kelly, M; Melanophy, G; Merry, C; Moriarty, M; O'Connor, R; O'Riordan, R; Relihan, E; Townsend, L	1
Behillil, S; Brisebarre, A; Calatrava, MR; Chapon, C; Contreras, V; de Lamballerie, X; Dereuddre-Bosquet, N; Enouf, V; Fang, RHT; Gonçalves, A; Guedj, J; Hoen, B; Kahlaoui, N; Le Grand, R; Lemaitre, J; Lina, B; Maisonnasse, P; Marlin, R; Naninck, T; Pizzorno, A; Solas, C; Terrier, O; Touret, F; van der Werf, S	1
Choi, JJ; Goyal, P; Gulick, RM; Kondo, M; Magleby, R; Maldarelli, GA; Pham, K; Rennert, H; Safford, MM; Satlin, MJ; Schenck, EJ; Westblade, LF	1
Abreu-Silva, EO; Amazonas, RB; Avezum, A; Azevedo, LCP; Berwanger, O; Bocchi de Oliveira, MF; Cardoso, FF; Cavalcanti, AB; Damiani, LP; Dantas, VCS; de Barros E Silva, PGM; Echenique, LS; Falavigna, M; Freitas, FGR; Furtado, RHM; Gebara, OCE; Golin, NA; Hoffmann Filho, CR; Junqueira, DLM; Kawano-Dourado, L; Kormann, APM; Laranjeira, LN; Lisboa, T; Lopes, RD; Machado, FR; Maia, IS; Marcadenti, A; Milan, EP; Pereira, AJ; Rosa, RG; Serpa-Neto, A; Soares, AT; Tramujas, L; Veiga, VC; Zampieri, FG	1
Argyraki, A; Boletis, I; Grigorakos, K; Lourida, P; Marinaki, S; Skalioti, C; Tsiakas, S	1
Akova, M; Alp, A; Alp, Ş; Çalık Başaran, N; İnkaya, AÇ; Karahan, S; Metan, G; Öz, ŞG; Özışık, L; Şahin, TK; Sain Güven, G; Taş, Z; Telli Dizman, G; Topeli, A; Ünal, S; Uyaroğlu, OA; Uzun, Ö; Zarakol, P	1
Ahmad, Z; Asif, H; Khan, F; Khan, S; Zia-Ur-Rahman, A	1
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A	1
Baghel, P; Kadam, V; Karanam, R; Saseedharan, S	1
Etxeandia-Ikobaltzeta, I; Humphrey, LL; Qaseem, A; Yost, J	1
Argov, Z; Gotkine, M; Haham, N; Orenbuch-Harroch, E; Rein, N; Romain, M; Vaknin-Dembinsky, A	1
Zampieri, FG	1
Braz, HLB; de Moraes, MEA; Jorge, RJB; Marinho, AD; Monteiro, HSA; Moraes Filho, MO; Silveira, JAM	1
Holtgrave, DR; Rosenberg, ES; Udo, T	1
Malviya, A	1
Bai, F; Cozzi-Lepri, A; d'Arminio Monforte, A; Marchetti, G; Tavelli, A	1
Atkinson, JG	1
Bartolomei, M; Biagetti, C; Capucci, A; Dappozzo, A; Paolizzi, C; Piovaccari, G; Santarelli, A	1
Guharoy, R; Krenzelok, E	1
Kulasegarah, J; Saniasiaya, J	1
Azria, P; Borie, MF; Guillerm, JC; Hubert, S; Lorc'h, EL; Mahé, A; Ménage, E; Mourad, JJ; Voisin, O	1
Barbonetti, A; Berardicurti, A; Berardicurti, O; D'Andrea, S; Felzani, G; Francavilla, F; Francavilla, S; Giacomelli, R	1
Attanasi, M; Caronni, A; Centanni, S; Chiarelli, F; Cimino, MM; Cipolla, G; Di Pillo, S; Faverio, P; Pasini, S; Pellegrino, GM; Sferrazza Papa, GF	1
Baddley, J; Beekmann, S; Brunton, AE; Calabrese, C; Calabrese, L; Curtis, JR; Polgreen, P; Robinson, PC; Saag, KG; Wallace, ZS; Winthrop, KL	1
Canales-Albendea, M; Casado-Abad, G; de la Cruz-Benito, B; de Soto-Álvarez, T; Dos Santos-Ortas, A; García-Pérez, E; Humala-Barbier, K; Jiménez-Yuste, V; Lázaro-Del Campo, P; López-de la Guía, A; Ramírez-López, A; Sánchez-Vadillo, I	1
Atalla, E; Aung, S; Brotherton, A; Cunha, CB; Kalligeros, M; Larkin, J; Mylona, EK; Mylonakis, E; Pandita, A; Sanchez, M; Shah, R; Shehadeh, F; Touzard-Romo, F	1
Munic Kos, V; Norgren, K; Norinder, U; Tuck, A	1
Akhter, N; Almalki, SS; Dar, SA; Haque, S; Wahid, M	1
Wiseman, DM	1
Brito-Azevedo, A	1
Akram, J; Azhar, S; Khan, KS; Latif, W; Shahzad, M	1
Johnson, ML; Thornton, D; Varisco, TJ	1
Barba-Gyengo, N; Cabrero-Rodríguez, C; Fernández-García, MÁ; Gámez-Baeza, P; Gámiz-Molina, AB; García-Martín, M; Guirado-Ruiz, PA; Jiménez-Mejías, E; Láinez-Ramos-Bossini, AJ; Mancera-Romero, J; Martín-delosReyes, LM; Martín-Romero, DT; Martínez-Diz, S; Martínez-Ruiz, V; R-delAmo, JL; Rivera-Izquierdo, M; Rodríguez-Camacho, M; Sánchez-Pérez, MR; Tahery-Mahmoud, A; Valero-Ubierna, MDC	1
Asif, A; Balani, B; Barsky, C; Bednarz, U; Berry, DA; Berry, NS; Berry, SM; Biran, N; Cicogna, C; Go, RC; Goldberg, SL; Goy, AH; Hansen, E; Ip, A; Jacobs, LG; Korcak, J; Landolfi, JC; Marafelias, M; Mathura, S; Pecora, AL; Piwoz, JA; Rose, KM; Sawczuk, IS; Sebti, R; Sinclaire, BA; Sperber, S; Sugalski, G; Tank, L; Timmapuri, SL; Underwood, JP; Varga, DW; Zuckerman, J	1
Álvaro-Gracia, J; Castrejón, I; González, T; Martínez-Barrio, J; Molina Collada, J; Montero, F; Rivera, J; Serrano-Benavente, B	1
Chicharro, P; De Argila, D; Llamas-Velasco, M; Muñoz-Aceituno, E; Muñoz-Hernández, P; Rodríguez-Jiménez, P	1
Allou, N; Allyn, J; André, M; Borsu, K; Bruneau, L; Coolen-Allou, N; Dibernardo, S; Dubernet, A; Foch, E; Gauzere, L; Jabot, J; Jaffar-Bandjee, MC; Lagrange-Xelot, M; Larsen, K; Maillot, A; Masse, L; Moreau, D; Raffray, L; Renaud, S; Thomas, V	1
Gülen, B; Mehmetaj, L; Özcan, AB; Taşlıdere, B; Taşlıdere, N	1
Ambati, J; Cummings, TH; Hardin, JW; Magagnoli, J; Narendran, S; Pereira, F; Sutton, SS	1
Bataille, S; Bergounioux, JP; Brunner, F; Giaime, P; Guenoun, M; Guilhaumou, R; Narbonne, H; Ollier, J; Pedinielli, N; Sampol, J; Serveaux, M; Sichez, H; Solas, C	1
Chowdhury, J; Criner, G; D'Alonso, G; Fleece, D; Gangemi, A; Giurintano, J; Gordon, M; Gupta, R; Marron, R; Mills, N; Patel, M; Patlakh, N; Rali, P; Tragesser, L; Yousef, I; Zhao, H; Zheng, M	1
Cheng, G; Li, C	1
Ahmadinejad, Z; Ghiasvand, F; Golestan, FS; Hajiabdolbaghi, M; Jafari, F; Jafari, S; Jamalimoghadamsiahkali, S; Khalili, H; Kouchak, HE; Manafi, N; Pirhayati, M; Sadr, S; Salehi, M; Seifi, A; Sekhavati, E; SeyedAlinaghi, S; Tabarestani, M; Zendehdel, A	1
Ding, C; García, JA; García-Abellán, J; García-Pachón, E; Guillén, L; Gutiérrez, F; Masiá, M; Mora, A; Padilla, S; Telenti, G	1
Amézaga Menéndez, R; Catalán González, M; Díaz, E; Escapa, MG; Marcos Neira, P; Quintana Díaz, M; Serrano Lázaro, A; Suberviola, B; Vidal Cortés, P	1
Al-Makki, A; Taber, T	1
D'Agostino McGowan, L; Fox, MP; James, BD; Lessler, J; Mehta, SH; Murray, EJ	1
Fiolet, T; Guihur, A; Mahamat-Saleh, Y; Mulot, M; Peiffer-Smadja, N; Rebeaud, ME	3
Bellolio, F; Oliveira J E Silva, L; Vidor, MV; Zarpellon de Araújo, V	1
Akar, JG; Hummel, JP	1
Campos-Staffico, AM; Lopez-Medina, AI; Luzum, JA	1
Birlutiu, V; Iancu, GM; Solomon, A	1
Alvarado, R; Azañero, R; Chávez, C; Chumbes-Aguirre, M; García-Saavedra, MB; Polo, R; Rosales-Gutiérrez, RR; Valverde, E	1
Abasifar, H; Dadkhahfar, S; Gheisari, M; Mortazavi, N; Nasiri, S	1
Fatima, S; Fatima, U; Hassan, MI; Rizvi, SSA	1
Al Rihani, SB; Arwood, M; Cicali, B; Deodhar, M; Dow, P; Michaud, V; Turgeon, J	1
Balzarini, L; Bossoni, E; Dodi, C; Inama, G; Inama, L; Mancini, C; Marvisi, M; Provini, M; Ramponi, S	1
Sher, DJ	1
Amazonas, RB; Avezum, A; Azevedo, LCP; Berwanger, O; Castilho, K; Cavalcanti, AB; Corrêa, TD; Dantas, VCS; Ferraz, LR; Fonseca, HA; Furtado, RHM; Gebara, OCE; Lapa, MG; Lisboa, TC; Lopes, RD; Machado, FR; Manoel, ALO; Martins, PA; Milan, EP; Moia, DDF; Momesso, RGRAP; Neto, AS; Olivato, GB; Oliveira, MB; Pereira, AJ; Piano, LPA; Piza, FMT; Rizzo, LV; Rosa, RG; Schettino, GPP; Soares, RVP; Veiga, VC; Zampieri, FG	1
Antonijević Miljaković, E; Antonijević, B; Baralić, K; Buha Djordjevic, A; Ćurčić, M; Jorgovanović, D; Živančević, K; Đukić-Ćosić, D	1
Alves-Costa-Silva, C; Derosa, L; Ferrere, G; Kepp, O; Kroemer, G; Liu, P; Ly, P; Tian, AL; Wu, Q; Zhao, L; Zitvogel, L	1
Grosso, P; Ippoliti, G; Lauriola, M; Mazen, M; Milighetti, S; Mortara, A; Pani, A; Pastori, D; Perseghin, G; Scaglione, F	1
Ahuja, T; Carlucci, PM; Jones, S; Petrilli, C; Rahimian, J; Rajagopalan, H	1
Gold, HS; Maher, TR; McCoy, CM; Mercuro, NJ; Shim, DJ; Yen, CF; Zimetbaum, PJ	1
Bonow, RO; Hernandez, AF; Turakhia, M	1
Argaud, L; Bessière, F; Charrière, R; Chevalier, P; Cour, M; Delinière, A; Roccia, H	1
Chang, KJ; Chang, YL; Chien, CS; Chou, CY; Liu, CH; Yang, TH; Yang, TY; Yang, YF; Yang, YP; Yarmishyn, AA	1
Jones, CW; Platts-Mills, TF; Woodford, AL	1
Bernardini, A; Castelvecchio, S; Ciconte, G; de Innocentiis, C; Giannelli, L; Locati, ET; Marrocco-Trischitta, MM; Mecarocci, V; Menicanti, L; Negro, G; Pappone, C; Rondine, R; Santini, F; Vicedomini, G; Viva, T; Witkowska, E	1
Abdou, D; Aboelyazed, S; Aly, T; Amin, M; Eid, Y; El-Shayeb, M; Elziaty, R; Osman, A; Saeed, A; Samy, S; Sheha, A; Sheha, D	1
Chiricozzi, A; Garcovich, S; Giovanardi, G; Malvaso, D; Peris, K	1
Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A	1
Lagier, JC; Million, M; Raoult, D; Roussel, Y	1
Shah, RR	1
Lacout, A; Marcy, PY; Perronne, C	1
Alessandri, F; Ceccarelli, G; d'Ettorre, G; Dell'Isola, S; Oliva, A; Pugliese, F; Rocco, M; Ruberto, F; Venditti, M	1
Padern, G; Pers, YM	1
Chang, D; Epstein, LM; Fishbein, J; Gabriels, J; Mountantonakis, SE; Qiu, M; Saleh, M	1
Hasan, SS; Kow, CS	1
AlDosary, O; Garbati, MA; Gerberi, D; Kashour, T; Kashour, Z; Murad, MH; Riaz, M; Sohail, MR; Tlayjeh, H; Tleyjeh, IM	1
Dincer, MT; Karaca, C; Murt, A	1
Athan, E; Berk, M; Bortolasci, CC; Carvalho, AF; Maes, M; Marx, W; Morris, G; O'Neil, A; Puri, BK; Walder, K	1
Choo, SY	1
Mamishi, S; Navaeian, A; Shabanian, R	1
Amarasekera, AT; Kayes, T; Kodsi, M; MacIntyre, CR; Malaty, M; Tan, TC	1
Katayama, M; Mori, N; Nukaga, S	1
Bacis, G; Butera, R; Contessa, G; Eleftheriou, G; Falchi, G; Faraoni, L; Gallo, M; Giampreti, A; Negri, G; Sangiovanni, A	1
Borg, D; Borg, J; Casha, R; Farrugia, J; Fenech, M; Fsadni, C; Mallia Azzopardi, C; Mallia, D; Micallef, S; Piscopo, TV; Portelli, A; Vella, C; Vella, SM; Xerri, T; Zammit, MA	1
Ben-Chetrit, E; Bnaya, A; Einav, S; Feldman, I; Fteiha, B; Karameh, H; Kurd, R; Orlev, A; Ziff-Werman, B	1
García-Briones, A; González-Chon, O; Gutiérrez-Villaseñor, AO; Juárez-Hernández, E; Romero-González, JP; Sosa-García, JO	1
Buttazzi, R; Di Mario, S; Gagliotti, C; Moro, ML; Ricchizzi, E; Tedeschi, S	1
Chan, YY; Chen, HY; Chen, YH; Lai, EC; Shao, SC	1
Cambra-Poveda, C; García-Fernández, A; Ibáñez-Criado, A; Martínez-Martínez, JG; Moreno-Pérez, Ó; Ramos-Ruiz, P	1
Biering-Sørensen, T; Browatzki, A; Bødtger, UCS; Eklöf, JV; Jensen, JS; Knop, FK; Lappere, TS; Laursen, CB; Lundgren, JD; Meyer, CN; Shaker, SB; Sivapalan, P; Ulrik, CS; Weinreich, UM	1
Berling, I; Gosselin, S; Hoffman, RS	1
Bianco, M; Biolè, CA; Cerrato, E	1
Gold, HS; Shim, DJ; Yen, CF	1
Paul, M	1
Khan, AA; Khan, Z	1
Horniczká, K; Makovník, M; Palacka, P; Pazderová, N; Pörsök, Š; Šálek, T; Slopovský, J; Stankovič, I; Zomborská, E	1
Derwand, R; Scholz, M; Zelenko, V	1
Clavenna, A; Gallus, S; Lugo, A	1
Bouthors, AT; Gayet, S; Lacout, A; Vedrines, N	1
Aytekin, S; Aytekin, V; Çelik, HG; Ergönül, Ö; Kapmaz, M; Keske, Ş; Özyıldırım, A; Şahin, ŞT; Şener, Ü; Tekbaş, M	1
Berindan-Neagoe, I; Cismaru, CA; Cismaru, GL; Seyed Nabavi, F; Seyed Nabavi, M	1
Niburski, K; Niburski, O	1
Caliskan, S; Gunay, S; Sahin, E; Sigirli, D	1
Chen, HP; Chen, PL; Chen, SJ; Chen, YM; Chou, TY; Chuang, C; Feng, JY; Ho, HL; Hsiao, YH; Huang, SF; Lin, YT; Wang, FD	1
Akat, H; Laloglu, F; Orbak, Z	1
Aguado, JM; Andrés, A; Caravaca-Fontán, F; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F; Morales, E; Praga, M; Sevillano, Á; Trujillo, H	1
Arlotto, S; Augier, P; Chabriere, E; Coquet, A; Daher, G; Finaud, M; Gautret, P; Gentile, S; Labarriere, B; Laforge, V; Le-Dinh, P; Ly, TDA; Malfuson-Clot-Faybesse, P; Mendizabal, H; Midejean, A; Morel, D; Morel-Roux, AM; Parola, P; Quenette, O; Raoult, D; Zanini, D	1
Anderson, BR; Argenio, M; Bacha, EA; Chung, WK; Fremed, M; Krishnan, U; Levasseur, S; Lewis, MJ; Lytrivi, ID; Rosenbaum, M; Rosenzweig, EB; Sommer, R; Starc, TJ; Vincent, J; Weller, R	1
Ahmed, AAQ; Bakadia, BM; Boni, BO; He, F; Lamboni, L; Mukole, BM; Souho, T; Ullah, MW; Yang, G	1
Abbas, HM; Abdulelah, MM; Al Jubouri, AM; Al Khames, QA; Al-Jumaili, AA; Al-Obaidy, MW; Dakhil, BD; Nassir, KF	1
Abers, MS; Alehashemi, S; Bettini, LR; Biondi, A; Bonfanti, P; Brugnoni, D; Burbelo, PD; Calvo, KR; Canna, SW; Castagnoli, R; Castelli, F; Chertow, DW; Cohen, JI; D'Angio', M; de Jesus, AAA; Delmonte, OM; Desai, JV; DiNubile, MJ; Dobbs, K; Fink, DL; Fintzi, J; Gallin, JI; Gliniewicz, EF; Goldbach-Mansky, R; Imberti, L; Kahle, DE; Kuhns, DB; Levinson, SL; Licari, A; Lionakis, MS; Marseglia, GL; Montagna, D; Myint-Hpu, K; Notarangelo, LD; Oikonomou, V; Quiros-Roldan, E; Rastegar, AT; Ricotta, EE; Rossi, C; Shakoory, B; Shaw, E; Sottini, A; Stack, M; Su, HC; Tsang, JS; Zarember, KA	1
Belmas, AS; Danion, F; Fourtage, M; Gourieux, B; Michel, B; Nai, T; Nivoix, Y; Reisz, F; Reiter-Schatz, A; Ruch, Y; Walther, J	1
Ahmadinejad, Z; Ghadimi, M; Ghiasvand, F; Jafari, F; Manafi, N; Sadr, S; Seyed Alinaghi, SA; Tirgar, S	1
Anglada, M; Boix, M; Castillo, J; Curbelo, Y; Garibaldi, P; Gonzalez, E; Heras, E; Llovera, R; Llull, P; Mendoza, O; Miralles, JC; Piqué, JM; Valero, O	1
Kashour, T; Tleyjeh, IM	1
De Schryver, N; Gérard, L; Serck, N; Vinetti, M	1
Keane, MJ	1
Bohra, GK; Choudhary, R; Kumar, D	1
Berwanger, O; Cavalcanti, AB; Zampieri, FG	1
Anderson, KC; Goldberg, AD; Hewitt, K; Hicks, LK; Neuberg, DS; Niemeyer, CM; Pennell, NA; Plovnick, RM; Sehn, LH; Sekeres, MA; Tallman, MS; Thompson, JC; Tucker, E; Wood, WA	1
Bilge, AR; Çetin, N; Gündüz, R; Özdemir, İH; Özen, MB; Özlek, B	1
Benouna, ME; Ech-Chenbouli, A	1
Aboufazeli, E; Baradaran, H; Dadgostar, E; Ebrahimzadeh, MA; Eftekhari, A; Ghasemian, R; Hessami, A; Heydari, K; Jafarpour, H; Karimifar, K; Navaei, RA; Sadeghnezhad, R; Sedaghat, M; Shamshirian, A; Shamshirian, D; Tirandazi, B; Yazdi, SM; Yip, GW	1
Ak, R; Doganay, F; Seyhan, AU; Topal, NP; Yilmaz, E	1
Bermúdez-Jiménez, F; Flores, PIG; Gallo-Padilla, L; García, CM; García, JDM; Jiménez-Jáimez, J; López, MÁ; Macías-Ruiz, R; Molina, CF; Ramírez-Taboada, J; Rubini-Costa, R; Suárez, SM; Tercedor, L	1
Holub, M; Štěchovská, K; Zlámal, M	1
Haddad, F; Herth, FJF; Sakoulas, G	1
Bottieau, E; Catteau, L; Dauby, N; Goetghebeur, E; Hautekiet, J; Montourcy, M; Van Beckhoven, D	1
Almaghraby, A; Beshir, H; Ghazy, RM; Kamal, A; Moursi, A; Ramadan, A; Shaaban, R; Taha, SHN	1
Barreca, GS; Cancelliere, A; Davoli, C; La Gamba, V; Lio, E; Matera, G; Mazzitelli, M; Pelle, MC; Procopio, G; Quirino, A; Ricchio, M; Tassone, B; Torti, C; Trecarichi, EM	1
Dingding, Q; Jiangfang, L; Yujia, W; Zequn, Z	1
Burgess, LH; Jackson, E; Korwek, K; McLean, L; Miller, K; Perlin, JB; Poland, RE; Roach, J; Sands, K; Wenzel, R	1
Bandyopadhyay, D; Deb, S; Ganguly, U; Lahiri, D; Mondal, R; Pramanik, S; Shome, G	1
An, MH; Hwang, TH; Kim, MS; Kim, WJ	1
Colson, P; Gautret, P; Hoang, VT; Honoré, S; Lagier, JC; Raoult, D	1
Chaudet, H; Gautret, P; Hoang, VT; Lagier, JC; Raoult, D	1
Chen, J; Liu, D; Lu, H; Yin, L; Zhang, L	1
Isaza-Pierotti, DF; Martinez-Arboleda, JJ; Parra-Lara, LG; Rosso, F	1
Granwehr, BP; Malek, AE	1
Gautret, P; Million, M; Raoult, D; Roussel, Y	1
Diaz, G; Goldman, JD; Urba, WJ	1
Wambier, CG	1
Dos Santos, MR	1
El Bakkouri, K	1
Saad, MO	1
Gautret, P; Honoré, S; Lagier, JC; Raoult, D	1
Nguyen, TV	1
Gautret, P; Hoang, VT; Lagier, JC; Raoult, D	1
Colson, P; Gautret, P; La Scola, B; Lagier, JC; Raoult, D	1
Gautret, P; Hoang, VT; Honoré, S; Lagier, JC; Million, M; Raoult, D; Roussel, Y	1
Shan, G; Wang, W	1
Gautret, P; Hoang, VT; Honoré, S; Lagier, JC; Raoult, D	1
Kepp, O; Kroemer, G; Leduc, M; Liu, P; Martins, I; Tian, AL; Wu, Q; Zhao, L	1
Bande, F; Georges, K; Ishaka, A; Ismaila, MS; Sani, AA	1
Anton-Vazquez, V; Clivillé, R	1
Ghadami, M; Imani-Saber, Z; Mahdian, M; Safari, F; Vaseghi, H	1
Alhashmi, A; Belfaqeeh, O; Janapala, RN; Patel, J; Pourmand, A	1
Abbas, AE; Bradley, CJ; Dmitrienko, A; Gaines, R; Haines, DE; O'Connell, TF; Rusia, A; Schott, J; Tawney, AM; Williamson, BD	1
Abi-Gerges, N; Dumotier, B; Ghetti, A; Jordaan, P; Miller, PE; Traebert, M; Urban, L	1
Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M	1
Duverger, E; Herlem, G; Picaud, F	1
Gómez-Valent, M; Moreno-Ariño, M; Ortonobes Roig, S; Soler-Blanco, N; Torrente Jiménez, I; Van den Eynde Otero, E	1
Deharo, JC; Fiorina, L; Franceschi, F; Gardella, C; Hourdain, J; Koutbi-Franceschi, L; Maille, B; Martinez, E; Million, M; Rességuier, N; Singh, JP; Tissot-Dupont, H; Wilkin, M; Zabern, M	1
Schiattarella, A; Sisti, A; Sisti, G	1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M	1
Ehrlich, H; Elkbuli, A	1
Belmans, A; Gyselinck, I; Janssens, W; Landeloos, E; Liesenborghs, L; Verbeke, G; Verhamme, P; Vos, R	1
Lacout, A; Lounnas, V; Perronne, C	2
Horby, P; Landray, MJ; White, NJ	1
Colson, P; Gautret, P; Hoang, VT; Raoult, D	1
Benfield, TL; Damkier, P; Gronau, QF; Helweg-Larsen, J; Hulme, OJ; Madelung, CF; Madsen, KH; Siebner, HR; Wagenmakers, EJ	1
Baeza-Flores, GDC; Denis-García, CA; Flores-Barrientos, OI; Gonzalez-Castro, TB; Guzmán-Priego, CG; Juárez-Rojop, IE; López-Brito, CR; Narváez-Osorio, V; Nolasco-Rosales, GA; Pérez-García, A; Ruíz-Quiñonez, JA; Tovilla-Zarate, CA	1
Furuya, K; Goudarzi, H; Ohe, M	1
Bahlaoui, A; Chekhlabi, N; Dini, N; El Kettani, C; Ettair, S; Haoudar, A; Mahi, M	1
Eleftheria, K; Eleni, M; Evangelia, M; Evangelos, B; Ioannis, K; Vana, S; Vasilios, V; Vissaria, S	1
Aweeka, F; Gingrich, D; Huang, L; Marzan, F; Sok, V	1
Guo, J; Li, W; Szendrey, M; Yang, T; Zhang, S	1
Berns, SA; Ershov, FI; Myasnikov, AL; Talyzin, PA	1
Barary, M; Ebrahimpour, S; Eftekhar, SP; Javanian, M; Kazemi, S; Ziaei, N	1
Seligmann, H	1
Gautret, P; Ly, TDA; Raoult, D	1
Brouqui, P; Deharo, JC; Gautret, P; Hache, G; Honoré, S; Raoult, D; Rolain, JM	1
Albayrak, A; Allen, J; Asubonteng, J; Belli, A; Bhat, A; Brown, T; Cho, K; Das, R; Eldridge, E; Gatto, N; Gelman, A; Gerlovin, H; Goldberg, SL; Hansen, E; Hirsch, J; Ho, YL; Ip, A; Izano, M; Jones, J; Justice, AC; Klesh, R; Kuranz, S; Lam, C; Mao, Q; Mataraso, S; Mera, R; Posner, DC; Rassen, JA; Rodriguez-Watson, C; Schrag, A; Siefkas, A; Sigal, EV; Stewart, M; Tourassi, G; Weckstein, A; Winckler, S; Wolf, F	1
Brañez-Condorena, A; Diaz-Arocutipa, C; Hernandez, AV	1
Araújo, APDC; Braz, HLB; Charlie-Silva, I; da Luz, TM; Estrela, FN; Jorge, RJB; Malafaia, G	1
Bellos, I	1
Ahuja, B; Biswas, PS; Choudhuri, AH; Duggal, S	1
Contreras, AG; Flores-García, NC; García-Juárez, I; Hoyo, I; Márquez-Guillén, E; Páez-Zayas, VM; Pérez-González, B; Rodríguez-Aguilar, EF; Thomas-Lora, FC; Visag-Castillo, V	1
Charrez, B; Charwat, V; Edwards, AG; Finsberg, H; Healy, KE; Miller, EW; Siemons, B	1
Akhtar, Z; Breathnach, A; Chen, Z; Elbatran, AI; Ewasiuk, V; Fluck, DS; Gallagher, MM; Gregory, L; Leung, LWM; Madden, B; Sharma, S; Yap, YG	1
Abrams, MP; Avula, UMR; Baksh, H; Berman, JP; Biviano, A; Chai, Z; Chen, Q; Desai, AD; Dizon, JM; Ehlert, F; Elias, P; Garan, H; Hennessey, JA; Kemal, C; Kubin, CJ; Kushnir, A; LaSota, E; Morrow, JP; Poterucha, TJ; Rubin, DA; Rubin, GA; Saluja, D; Schwartz, A; Sobieszczyk, ME; Uriel, N; Waase, MP; Wan, EY; Wang, A; Wang, AS; Yarmohammadi, H; Zucker, J	1
Bianco, A; Cazzola, M; de Novellis, V; Matera, MG; Rogliani, P	1
Budhathoki, P; Khadka, S; Rawal, E; Shrestha, DB	1
Saint-Gerons, DM; Tabarés-Seisdedos, R	1
Avcı, İY; Çetinkaya, RA; Demirtürk, N; Eser, F; Güner, R; Karalezli, A; Kayaaslan, B; Konya, P; Okumuş, N; Orhan, S; Savaşçı, Ü; Şaylan, B; Taşkın, G; Yamanel, L; Yılmaz, G	1
Bakhshaliyev, N; Özdemir, R	1
Ahmed, WU; Alghoul, H; Alser, O; Alshammari, TM; Areia, C; Burn, E; Carter, W; Casajust, P; Cho, J; Dawoud, D; Duarte-Salles, T; Golozar, A; Gong, M; Hripcsak, G; Jonnagaddala, J; Kostka, K; Lai, LYH; Lane, JC; Liu, L; Lynch, KE; Matheny, ME; Mehta, PP; Morales, DR; Nyberg, F; Posada, JD; Prats-Uribe, A; Prieto-Alhambra, D; Recalde, M; Reich, C; Rijnbeek, PR; Roel, E; Ryan, PB; Schilling, LM; Sena, AG; Shah, K; Shah, NH; Subbian, V; Suchard, MA; Vizcaya, D; You, SC; Zhang, L; Zhang, Y; Zhu, H	1
Baró, I; Charpentier, F; De Waard, M; Loussouarn, G; Montnach, J	1
Abraham, A; Austin, C; Bent, S; Boscardin, WJ; Bravata, DM; Kelly, JD; Keyhani, S; Lau, N; Leonard, S; Lietman, T; Lopez, L; Lum, E; Oldenburg, CE; Shlipak, MG; Zhang, Y; Zillich, A	1
Abeles, SR; Jia, S; Kwon, J; Mehta, SR; Nan, B; Watanabe, JH	1
Becker, M; Benstoem, C; Iannizzi, C; Metzendorf, MI; Meybohm, P; Mikolajewska, A; Piechotta, V; Skoetz, N; Stegemann, M; Stroehlein, JK; Wallqvist, J	1
de Almeida, DC; de Souza, AA; Dos Santos, DRP; Ferreira, PRA; Franco, MDCP; Goes, MA; Machado, FR; Maltoni, IS; Mascotte, F; Medeiros, EA; Pietrobom, PM; Santos, MC	1
Abu-Izneid, T; Almalki, FA; Alqahtani, AM; Ben Hadda, T; Berredjem, M; Emran, TB; Esharkawy, E; Jamalis, J; Rastija, V; Rodriguez, LC	1
Abid, H; Abkari, ME; Adil, N; Aqodad, N; M'bodj, K	1
Carrillo-García, P; Garmendia-Prieto, B; Gómez-Pavón, J	1
Alkan, G; Artac, H; Emiroglu, M; Oz, SKT	1
Bech Rasmussen, D; Bergsøe, C; Biering-Sørensen, T; Bojesen, RD; Browatzki, A; Brøndum, E; Bødtger, U; Eklöf, J; Frydland, MS; Ghanizada, M; Gottlieb, V; Graff Jensen, S; Håkansson, KEJ; Høgsberg, D; Jensen, JS; Jordan, A; Klausen, TW; Knop, FK; Lange, P; Lapperre, TS; Lundgren, JD; Meteran, H; Pedersen, L; Priemé, H; Sivapalan, P; Steffensen, IE; Sverrild, A; Søborg, C; Tidemandsen, C; Tupper, O; Ulrik, CS; Wilcke, JT	1
Benito, N; Casademont, J; Castellví, I; Corominas, H; de la Rosa, D; Diaz-Torné, C; Domingo, P; Mangues, MA; Matas, L; Moga, E; Moya, P; Pomar, V; Sosa, NH	1
Amara, W; Cattan, S; Dellal, A; Nahon, S; Nallet, O; Nguyen, LS; Regaieg, K; Saib, A; Wang, P	1
Abdel-Rahman, MS; Algammal, AM; El-Saber Batiha, G; Elkady, AA; Farghaly, HSM; Hetta, HF; Koneru, G; Mabrok, M; Muhammad, K; Munawar, N; Ramadan, H; Waheed, Y	1
Begoli, E; Cho, K; Costa, L; Danciu, I; Freiberg, MS; Gagnon, DR; Gaziano, JM; Gerlovin, H; Goethert, ID; Ho, YL; Jacobson, DA; Justice, AC; King, JT; Kurgansky, KE; Linares, FA; Muralidhar, S; Posner, DC; Ramoni, RB; Rentsch, CT; Tate, JP; Tourassi, G	1
Issa, ME; Kazanova, A; Kremer, R; Krueger, J; Larrivee, B; Milhalcioiu, C; Rudd, CE; Santinon, F	1
Cetin, N; Ozyurtlu, F; Yavuz, V	1
Benito-González, T; Borrego-Rodríguez, J; Del Castillo-García, S; Echarte-Morales, J; Fernández-Vázquez, F; Flores-Vergara, G; García-Bergel, R; Iglesias-Garriz, I; Maniega, CG; Menéndez-Suárez, P; Minguito-Carazo, C; Palacios-Echavarren, C; Prieto-González, S; Rodríguez-Santamarta, M; Sánchez-Muñoz, E	1
Abou Warda, AE; El-Gazar, RA; Gaber, S; Sarhan, RM; Tammam, M	1
Cao, B; Xu, J	1
Baldi, E; D'Amore, S; Fraolini, E; Ghio, S; Masiello, L; Melazzini, F; Perlini, S; Rordorf, R; Seminari, EM; Tavazzi, G; Vicentini, A	1
Chi, G; Fitzgerald, C; Gibson, CM; Kazmi, SHA; Lee, JJ; Memar Montazerin, S; Shojaei, F	1
Ahmed, MAI; Braz, HLB; Charlie-Silva, I; da Costa Araújo, AP; da Luz, TM; Jorge, RJB; Malafaia, G; Mendonça-Gomes, JM; Nóbrega, RH; Vogel, CFA	1
Abid, H; Atmani, I; Benajah, DA; El Abkari, M; El Yousfi, M; Ibrahimi, SA; Lahmidani, N	1
Freitas-Santos, RS; Levi, JE; Lopes, ATA; Pierrotti, LC; Rodrigues, C; Santos, SR; Senerchia, AA; Siciliano, RF	1
Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO	1
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S	1
Abbasov, H; Abishov, E; Aksu, T; Akyay, A; Albayrak, C; Andıç, N; Ar, MC; Ataş, Ü; Aydın Kaynar, L; Balık Aydın, B; Baş, V; Baydar, M; Beköz, HS; Beksaç, M; Bolaman, AZ; Can, F; Çelik, S; Çeneli, Ö; Cengiz Seval, G; Çiftçiler, R; Civriz Bozdağ, S; Demir, AM; Demirci, U; Demircioğlu, S; Diz Küçükkaya, R; Doğan, A; Eroğlu Küçükdiler, H; Erol, V; Göksoy, HS; Güler, N; Gündüz, E; Gürman, G; Gürsoy, V; Güven, ZT; Hindilerden, F; İlhan, O; İnce, İ; Kaynar, L; Keklik, M; Kurt Yüksel, M; Maral, S; Mutlu, YG; Özcan, M; Özkalemkaş, F; Özkocaman, V; Özkurt, ZN; Özsan, GH; Sadri, S; Selim, C; Sevindik, ÖG; Terzi, H; Topçuoğlu, P; Toprak, SK; Ünal, Ş; Üsküdar Teke, H; Yağcı, M; Yavaşoğlu, İ; Yavuz, B; Yavuz, Y; Yegin, ZA; Yılmaz, U; Yönal Hindilerden, İ; Yücel, OK	1
Amrane, S; Aubry, C; Bendamardji, K; Berenger, C; Brouqui, P; Camoin-Jau, L; Cassir, N; Chaudet, H; Colson, P; Cortaredona, S; Deharo, JC; Delorme, L; Dhiver, C; Doudier, B; Edouard, S; Fournier, PE; Gaubert, JY; Gautret, P; Gentile, S; Giraud-Gatineau, A; Guillon-Lorvellec, K; Habert, P; Hocquart, M; Honore, S; Jacquier, A; Jouve, E; Lagier, JC; Mailhe, M; Maille, B; Million, M; Obadia, Y; Parola, P; Porcheto, C; Raoult, D; Ravaux, I; Seng, P; Tissot-Dupont, H; Tomei, C; Triquet, C	1
Andena, AM; Cattadori, E; Cavanna, L; Citterio, C; Codeluppi, M; Cremona, G; Gubbelini, M; Maniscalco, P; Muroni, L; Muroni, M; Nolli, M; Nunzio, CD; Pedrazzini, G; Schiavo, R	1
Ali, H; Edwards, J; Green, JL; Yendrapalli, U	1
Nogrady, B	1
Boudesseul, J; Harbert, A; Rubinos, C; Zerhouni, O	1
Cevenini, F; Fallani, E; Lazzerini, PE; Saponara, S; Verdini, A	1
Akarsu, M; Akgun, H; Murat, B; Murat, S; Ozmen, A	1
Heitmann, S; Hill, AP; Kerr, N; Mangala, M; McArthur, JR; Perry, MD; TeBay, C; Vandenberg, JI; Windley, MJ	1
Cochin, M; de Lamballerie, X; Driouich, JS; Laprie, C; Moureau, G; Nougairède, A; Petit, PR; Solas, C; Touret, F	1
Beltran-Ontiveros, LD; Benitez-Altamirano, GM; Carmona-Aguilera, Z; Fuentes-Gonzalez, MF; Hernández-Jimenez, CA; Lopez Luis, BA; Lopez-Vejar, C; Ordinola Navarro, A; Ramirez-Hinojosa, JP; Vera-Lastra, O	1
Aherfi, S; Andreani, J; Bideau, ML; Boschi, C; Colson, P; Delerce, J; Gendrot, M; Jardot, P; La Scola, B; Levasseur, A; Pradines, B	1
Boutjdir, M; Capecchi, PL; Chen, K; Chen, L; Cupelli, M; Gao, L; Gao, Q; Ginjupalli, VKM; Lazzerini, PE; Srivastava, U; Wang, Y; Xiao, Y; Xin, X; Zhang, W; Zhu, X	1
Begovać, J; Bogdanić, N; Močibob, L; Soldo, A; Vidović, T	1
Abdalla, S; Ahmed, R; Al Awadhi, A; Al Falasi, O; Alattar, Y; AlKaabi, S; Almubarak, A; Altaha, Z; Ansel Benette, H; El Kadri, M; Hillis, A; Oulhaj, A; Panikkaveetil, B; Saifuddin, M	1
Arosio, R; Bergamaschi, L; Forleo, GB; Gasperetti, A; Gherbesi, E; Mitacchione, G; Schiavone, M; Viecca, M	1
Barry, H; Boly, R; Diendéré, AE; Drabo, MK; Ouédraogo, AR; Ouedraogo, AS; Ouédraogo, E; Poda, A; Rouamba, T; Sondo, A; Tahita, MC; Tarnagda, Z; Tinto, H; Traoré, I; Valea, I; Yaméogo, NV; Zoungrana, J	1
Ioannidis, JPA	1
Hong, W; Hwang, TH; Jang, J; Jang, SP; Jang, SW; Kim, BO; Park, HW; Park, SK; Park, YK; Shin, J; Yang, W	1
Chotsiri, P; Hoglund, RM; Tarning, J; Watson, JA; White, NJ	1
Elliott, JH; Henry, D; Pearson, SA; Schaffer, AL; Zoega, H	1
Borges, P; Botton, MR; Freitas, M; Hentschke-Lopes, M; Mancuso, ACB; Matte, U	1
Bradley, MC; Chakravarty, A; Easthausen, IJ; Garry, EM; Gatto, NM; Lasky, T; Roe, LM; Vititoe, SE; Weckstein, AR	1
Fatarova, M; Guy, PA; Hoeng, J; Ivanov, NV; Kuczaj, A; Laszlo, C; Majeed, S; Mazurov, A; Pak, C; Peitsch, MC; Steiner, S; Vidal-de-Miguel, G; Zivkovic Semren, T	1
Diallo, M; Eyamamé, D	1
Alemu, A; Berhe, N; Bitew, ZW; Diriba, G; Gashu, E; Gumi, B; Mariam, SH; Seid, G	1
Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES	1
Gomes, MP; Guzman-Tordecilla, M; Juneau, P; Kochi, LY; Malage, L; Marques, RZ	1
Brouqui, P; Deharo, JC; Franceschi, F; Hourdain, J; Lagier, JC; Million, M; Parola, P	1
Cupp, MA; Hayes, KN; Lee, Y; Riester, MR; Silva, JBB; Zhang, Y; Zullo, AR	1
Aït Moussa, L; Alj, L; Khattabi, A; Meski, FZ; Sefiani, H; Soulaymani Bencheikh, R; Tebaa, A	1
Aguado-Sierra, J; Baron, AK; Brigham, R; Butakoff, C; Carreras, F; Filgueiras-Rama, D; Gomez, PD; Guerra, JM; Houzeaux, G; Iaizzo, PA; Iles, TL; Vazquez, M	1
Aldhafiri, WN; Arnold, SL; Barnabas, R; Chhonker, YS; Johnson, C; Karita, HCS; Murry, DJ; Paasche-Orlow, MK; Soni, D; Steinbronn, C; Trivedi, N	1
Aguiar, FC; Aguiar, RLO; Anschau, F; Bartolazzi, F; Batista, JDL; Bicalho, MAC; Costa, FR; Ferreira, MAP; Guimarães-Júnior, MH; Machado-Rugolo, J; Manenti, ERF; Marcolino, MS; Menezes, LSM; Nascimento, GF; Nogueira, MCA; Oliveira, LS; Pereira, DN; Pereira, EC; Pires, MC; Polanczyk, CA; Rios, DRA; Ruschel, KB; Schwarzbold, AV; Souza-Silva, MVR; Tofani, MGT; Vasconcelos, DH; Vasconcelos, IM; Vianna, HR; Ziegelmann, PK	1
Atamari-Anahui, N; Gómez-Ponce, V; Lipa-Chancolla, R; Nuñez-Paucar, H; Pérez-Garfias, F; Torres-Salas, JC; Untiveros-Tello, A; Valera-Moreno, C; Zamudio-Aquise, MK	1

Reviews

66 review(s) available for hydroxychloroquine and zithromax

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Side effects of medications used to treat childhood interstitial lung disease. Paediatric respiratory reviews, 2018, Volume: 28 Topics: Anti-Bacterial Agents; Antirheumatic Agents; Azithromycin; Child; Cyclophosphamide; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Methylprednisolone; Off-Label Use; Prednisolone; Rituximab	2018
Epidemiological analysis of COVID-19 and practical experience from China. Journal of medical virology, 2020, Volume: 92, Issue:7 Topics: Age Factors; Animals; Azithromycin; Betacoronavirus; China; Chiroptera; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; Humans; Hydroxychloroquine; Immunization, Passive; Infectious Disease Incubation Period; Pandemics; Pneumonia, Viral; Prevalence; SARS-CoV-2; Severity of Illness Index; Survival Analysis	2020
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment. Circulation, 2020, 06-16, Volume: 141, Issue:24 Topics: Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Heart Rate; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes	2020
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, Apr-27, Volume: 192, Issue:17 Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Monitoring, Physiologic; Pandemics; Patient Selection; Pneumonia, Viral; SARS-CoV-2	2020
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020, May-12, Volume: 323, Issue:18 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment	2020
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. Journal of medical virology, 2020, Volume: 92, Issue:7 Topics: Angiotensin-Converting Enzyme 2; Antibodies, Neutralizing; Antibody-Dependent Cell Cytotoxicity; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Glucose; Glycosylation; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Hyperglycemia; Incidence; Macrophages; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020
Annals of the rheumatic diseases, 2020, Volume: 79, Issue:6 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Rheumatologists; SARS-CoV-2	2020
Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. Journal of medical virology, 2020, Volume: 92, Issue:7 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Viral Load; Virus Replication	2020
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:2 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lung; Microbial Sensitivity Tests; SARS-CoV-2	2020
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1 Annales de cardiologie et d'angeiologie, 2020, Volume: 69, Issue:3 Topics: Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiomyopathies; Cardiovascular Diseases; Cerebrovascular Disorders; Chloroquine; Comorbidity; Coronary Disease; Coronavirus Infections; COVID-19; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Virus Internalization	2020
Treatment options for COVID-19: The reality and challenges. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin	2020
COVID-19: Immunology and treatment options. Clinical immunology (Orlando, Fla.), 2020, Volume: 215 Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Disease Management; Gene Expression Regulation; Humans; Hydroxychloroquine; Immune Evasion; Immunologic Factors; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Toll-Like Receptors; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins	2020
Cardiovascular manifestations and treatment considerations in COVID-19. Heart (British Cardiac Society), 2020, Volume: 106, Issue:15 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Azithromycin; Betacoronavirus; Biomarkers; Cardiovascular Diseases; Chloroquine; Comorbidity; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Extracorporeal Membrane Oxygenation; Humans; Hydroxychloroquine; Immunosuppressive Agents; Influenza, Human; Lung; Myocardium; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Troponin; Venous Thromboembolism	2020
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020, Volume: 59, Issue:2 Topics: Adult; Aged; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Risk Assessment	2020
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. The American journal of cardiology, 2020, 08-01, Volume: 128 Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Clinical drug investigation, 2020, Volume: 40, Issue:7 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral	2020
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say? Indian journal of public health, 2020, Volume: 64, Issue:Supplement Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Coronavirus Disease 2019: Clinical Review. Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment	2020
Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circulation. Heart failure, 2020, Volume: 13, Issue:7 Topics: Acute Coronary Syndrome; Anti-Bacterial Agents; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Cardiotonic Agents; Chronic Disease; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Extracorporeal Membrane Oxygenation; Heart Failure; Heart-Assist Devices; Humans; Hydroxychloroquine; Intra-Aortic Balloon Pumping; Myocardial Infarction; Myocarditis; Pandemics; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; Shock, Cardiogenic; Thromboembolism	2020
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. International journal of antimicrobial agents, 2020, Volume: 56, Issue:2 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunologic Factors; Long QT Syndrome; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Tackle the free radicals damage in COVID-19. Nitric oxide : biology and chemistry, 2020, 09-01, Volume: 102 Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome	2020
Left ventricular dysfunction in COVID-19: A diagnostic issue. Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3 Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypoxia; Long QT Syndrome; Myocardial Infarction; Myocarditis; Pandemics; Pericarditis; Pneumonia, Viral; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachycardia, Ventricular; Thrombophilia; Ventricular Dysfunction, Left; Ventricular Fibrillation	2020
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic. Irish journal of medical science, 2021, Volume: 190, Issue:1 Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Magnesium; Pandemics; Potassium; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Ritonavir; SARS-CoV-2; Torsades de Pointes	2021
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA network open, 2020, 07-01, Volume: 3, Issue:7 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Non-Randomized Controlled Trials as Topic; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein-Tyrosine Kinases; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Viral Load	2020
Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Outcome Assessment, Health Care; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2	2020
Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130 Topics: Anti-Inflammatory Agents; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chemical and Drug Induced Liver Injury; Chloroquine; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; Endosomes; Humans; Hydrogen-Ion Concentration; Hydroxychloroquine; Intracellular Membranes; Lysosomes; Membrane Lipids; Models, Biological; Pandemics; Phospholipids; Pneumonia, Viral; SARS-CoV-2; Surface-Active Agents; Virus Internalization	2020
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Frontiers in immunology, 2020, Volume: 11 Topics: Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Therapy, Combination; Humans; Hydroxychloroquine; Mice; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Virus Replication	2020
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. Medicina intensiva, 2021, Volume: 45, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Disease Progression; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunomodulation; Interferon-beta; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ritonavir; SARS-CoV-2	2021
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Antiviral Agents; Azithromycin; Bayes Theorem; Bias; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Risk; SARS-CoV-2; Standard of Care; Survival Analysis	2021
[Cardiovascular implications of SARS-CoV-2 infection: A literature review]. Medwave, 2020, Aug-28, Volume: 20, Issue:7 Topics: Acute Coronary Syndrome; Algorithms; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Heart Failure; Humans; Hydroxychloroquine; Hypertension; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Prognosis; Renin-Angiotensin System; SARS-CoV-2	2020
Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2020, Volume: 40, Issue:10 Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Synergism; Humans; Hydroxychloroquine; Immunologic Factors; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs. Clinical and translational science, 2021, Volume: 14, Issue:1 Topics: Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Long QT Syndrome; Risk Assessment; SARS-CoV-2	2021
An Ounce of Prevention and a Pound of Cure: Randomized Clinical Trials of Therapeutics Against COVID-19 and an Assessment of Personal Protective Equipment and Distancing. International journal of radiation oncology, biology, physics, 2020, 10-01, Volume: 108, Issue:2 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Personal Protective Equipment; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients. Journal of the Chinese Medical Association : JCMA, 2021, 02-01, Volume: 84, Issue:2 Topics: Azithromycin; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Humans; Hydroxychloroquine; Publication Bias; Randomized Controlled Trials as Topic; SARS-CoV-2	2021
Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:1 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Repositioning; Humans; Hydroxychloroquine; Long QT Syndrome; Treatment Outcome; Viral Load	2021
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Hydroxychloroquine; Randomized Controlled Trials as Topic; Treatment Outcome	2021
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Life sciences, 2020, Dec-01, Volume: 262 Topics: Antiviral Agents; Autophagy; Azithromycin; COVID-19; COVID-19 Drug Treatment; Endosomes; Humans; Hydroxychloroquine; Lysosomes; Pandemics; SARS-CoV-2	2020
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review. European journal of clinical investigation, 2021, Volume: 51, Issue:2 Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Azithromycin; Bradycardia; Cardiac Pacing, Artificial; COVID-19; COVID-19 Drug Treatment; Death, Sudden, Cardiac; Electric Countershock; Hospitalization; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; SARS-CoV-2; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Fibrillation	2021
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2; Treatment Outcome	2021
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Azithromycin; Ceftriaxone; COVID-19; Deprescriptions; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Hyperoxaluria, Primary; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nitriles; Oxygen Inhalation Therapy; Prednisone; Pyridines; Renal Dialysis; SARS-CoV-2; Sputum; Tacrolimus; Tomography, X-Ray Computed; Triazoles	2021
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Vaccines; Humans; Hydroxychloroquine; Interferons; Treatment Outcome	2021
The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis. Annals of the Academy of Medicine, Singapore, 2020, Volume: 49, Issue:10 Topics: Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Intubation, Intratracheal; Mortality; Severity of Illness Index; Treatment Outcome	2020
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Scientific reports, 2020, 12-17, Volume: 10, Issue:1 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2; Treatment Outcome	2020
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. European journal of pharmacology, 2021, Feb-15, Volume: 893 Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; ERG1 Potassium Channel; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Ritonavir	2021
Meningoencephalitis associated with COVID-19: a systematic review. Journal of neurovirology, 2021, Volume: 27, Issue:1 Topics: Adult; Aged; Antiviral Agents; Azithromycin; Confusion; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Electroencephalography; Fatigue; Female; Fever; Humans; Hydroxychloroquine; Male; Meningoencephalitis; Middle Aged; Neuroimaging; SARS-CoV-2	2021
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. PLoS medicine, 2020, Volume: 17, Issue:12 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Illness; Hospitalization; Humans; Hydroxychloroquine; Immunization, Passive; Network Meta-Analysis; Observational Studies as Topic; Randomized Controlled Trials as Topic	2020
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Hydroxychloroquine; Nasopharynx; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Statistics as Topic; Viral Load	2021
Therapeutic options for COVID-19: a quick review. Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk. Iranian journal of allergy, asthma, and immunology, 2020, Oct-18, Volume: 19, Issue:5 Topics: ADAM17 Protein; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Azithromycin; Betacoronavirus; COVID-19; COVID-19 Drug Treatment; Enzyme Inhibitors; Furin; Genetic Predisposition to Disease; Genome, Human; Genome, Viral; Humans; Hydroxychloroquine; Phylogeny; Precision Medicine; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Virus Internalization	2020
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. Journal of neurovirology, 2021, Volume: 27, Issue:1 Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid	2021
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis. Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:6 Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Observational Studies as Topic; Ritonavir	2021
A metaresearch study revealed susceptibility of Covid-19 treatment research to white hat bias: first, do no harm. Journal of clinical epidemiology, 2021, Volume: 136 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Bias; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis. Indian journal of medical microbiology, 2021, Volume: 39, Issue:2 Topics: Azithromycin; Comorbidity; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Hepatic transplant during SARS-CoV-2 (COVID-19) pandemic. A literature review. Cirugia y cirujanos, 2021, Volume: 89, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Blood Component Transfusion; COVID-19; COVID-19 Serotherapy; Graft Rejection; Humans; Hydroxychloroquine; Immunization, Passive; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Pandemics; Waiting Lists; Withholding Treatment	2021
Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. Journal of Nepal Health Research Council, 2021, Apr-23, Volume: 19, Issue:1 Topics: Azithromycin; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pneumonia, Viral; SARS-CoV-2	2021
Vitamin D supplementation for the treatment of COVID-19: a living systematic review. The Cochrane database of systematic reviews, 2021, 05-24, Volume: 5 Topics: 25-Hydroxyvitamin D 2; Adrenal Cortex Hormones; Adult; Azithromycin; Bias; Calcifediol; Cause of Death; Ceftriaxone; Cholecalciferol; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Vitamin D Deficiency; Vitamins	2021
What would be the impact of COVID-19 on liver function of a patient with chronic hepatitis B? About a case and literature review. The Pan African medical journal, 2021, Volume: 38 Topics: Adult; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Hepatitis B, Chronic; Hospitals, University; Humans; Hydroxychloroquine; Liver Function Tests; Male; Morocco; Tenofovir	2021
Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:10 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2; Vitamin D	2021
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials. Journal of medical virology, 2021, Volume: 93, Issue:12 Topics: Adult; Aged; Antiviral Agents; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Network Meta-Analysis; Randomized Controlled Trials as Topic; Respiration, Artificial	2021
COVID-19: potential therapeutics for pediatric patients. Pharmacological reports : PR, 2021, Volume: 73, Issue:6 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2021
Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19. Cardiac electrophysiology clinics, 2022, Volume: 14, Issue:1 Topics: Arrhythmias, Cardiac; Azithromycin; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Risk Factors; SARS-CoV-2	2022
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports. PloS one, 2022, Volume: 17, Issue:11 Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberculosis, Miliary	2022
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European journal of clinical pharmacology, 2023, Volume: 79, Issue:6 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2	2023

Trials

18 trial(s) available for hydroxychloroquine and zithromax

Article	Year
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Adult; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; Polymerase Chain Reaction; SARS-CoV-2; Viral Load	2020
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:4 Topics: Adult; Aged; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Young Adult	2020
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial. Annals of the American Thoracic Society, 2020, Volume: 17, Issue:8 Topics: Adult; Anti-Infective Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Monitoring; Female; Humans; Hydroxychloroquine; Male; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Utah	2020
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV Trials, 2020, 05-25, Volume: 21, Issue:1 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Administration Schedule; Health Status; Humans; Hydroxychloroquine; Ireland; Multicenter Studies as Topic; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome	2020
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials, 2020, Jun-10, Volume: 21, Issue:1 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Denmark; Double-Blind Method; Drug Administration Schedule; Hospital Mortality; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Inpatients; Length of Stay; Multicenter Studies as Topic; Noninvasive Ventilation; Pandemics; Patient Admission; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome	2020
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU. Trials, 2020, Jul-08, Volume: 21, Issue:1 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Double-Blind Method; Drug Therapy, Combination; Humans; Hydroxychloroquine; Intensive Care Units; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. The New England journal of medicine, 2020, 11-19, Volume: 383, Issue:21 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Treatment Failure	2020
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A struc Trials, 2020, Aug-08, Volume: 21, Issue:1 Topics: Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2	2020
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. International journal of antimicrobial agents, 2020, Volume: 56, Issue:4 Topics: Adult; Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Heart Rate; Humans; Hydroxychloroquine; Intensive Care Units; Lopinavir; Male; Middle Aged; Pandemics; Patient Safety; Pneumonia, Viral; Prognosis; Respiratory Function Tests; Ritonavir; SARS-CoV-2; Survival Analysis; T-Lymphocytes; Tomography, X-Ray Computed; Treatment Outcome	2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256 Topics: Aged; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiratory Therapy; SARS-CoV-2; Standard of Care; Treatment Outcome	2020
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. Trials, 2020, Oct-20, Volume: 21, Issue:1 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimalarials; Azithromycin; Betacoronavirus; Case-Control Studies; Coronavirus Infections; COVID-19; Denmark; Double-Blind Method; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Intention to Treat Analysis; Male; Noninvasive Ventilation; Pandemics; Placebos; Pneumonia, Viral; Risk Reduction Behavior; SARS-CoV-2	2020
Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial. International journal of clinical practice, 2021, Volume: 75, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19 Drug Treatment; Female; Hospitals, Special; Humans; Hydroxychloroquine; Iraq; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult	2021
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Drug Repositioning; Drug Synergism; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Nasopharynx; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Survival Analysis; Treatment Outcome; Viral Load	2021
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. Trials, 2021, Feb-09, Volume: 22, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Belgium; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Polymerase Chain Reaction; Proof of Concept Study; Randomized Controlled Trials as Topic; SARS-CoV-2; Standard of Care; Treatment Outcome; Young Adult	2021
[Interferon gamma in the treatment of patients with moderate COVID-19]. Voprosy virusologii, 2021, 03-07, Volume: 66, Issue:1 Topics: Aged; Ampicillin; Anti-Infective Agents; Anticoagulants; Azithromycin; Blood Pressure; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Hydroxychloroquine; Immunologic Factors; Interferon-gamma; Male; Middle Aged; Random Allocation; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vancomycin	2021
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC infectious diseases, 2021, May-04, Volume: 21, Issue:1 Topics: Aged; Amides; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; Pyrazines; Single-Blind Method; Treatment Outcome	2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial. The European respiratory journal, 2022, Volume: 59, Issue:1 Topics: Adolescent; Adult; Azithromycin; COVID-19 Drug Treatment; Double-Blind Method; Humans; Hydroxychloroquine; SARS-CoV-2; Treatment Outcome	2022
Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance. International journal of antimicrobial agents, 2021, Volume: 58, Issue:5 Topics: Adult; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Outpatients; Placebos; Treatment Outcome; Viral Load	2021

Other Studies

337 other study(ies) available for hydroxychloroquine and zithromax

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 2020, Volume: 583, Issue:7816 Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins	2020
Lysosomotropic drugs inhibit maturation of transforming growth factor-beta. Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:9 Topics: Amodiaquine; Animals; Azithromycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Cell Line; Cell Line, Tumor; Chloroquine; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Furin; Humans; Hydroxychloroquine; Kinetics; Lysosomes; Mice; Mice, Inbred C57BL; Phosphorylation; Stem Cells; Transforming Growth Factor beta	2008
ABCA3 transporter deficiency. American journal of respiratory and critical care medicine, 2012, Oct-15, Volume: 186, Issue:8 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; ATP-Binding Cassette Transporters; Azithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxychloroquine; Infant, Newborn; Lung Diseases, Interstitial; Lung Transplantation; Male; Methylprednisolone; Pulmonary Alveolar Proteinosis; Respiration, Artificial; Respiratory Distress Syndrome, Newborn	2012
Survival of an infant with homozygous surfactant protein C (SFTPC) mutation. Pediatric pulmonology, 2014, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Consanguinity; Genes, Recessive; Homozygote; Humans; Hydroxychloroquine; Infant; Lung; Male; Methylprednisolone; Microscopy, Electron; Mutation, Missense; Oxygen Inhalation Therapy; Pedigree; Phenotype; Pulmonary Alveolar Proteinosis; Pulmonary Surfactant-Associated Protein C; Radiography; Respiration, Artificial; Respiratory Distress Syndrome; Siblings; Treatment Outcome	2014
A New Medicina (Kaunas, Lithuania), 2019, Jul-19, Volume: 55, Issue:7 Topics: Adrenal Cortex Hormones; ATP-Binding Cassette Transporters; Azithromycin; Humans; Hydroxychloroquine; Infant, Newborn; Lung Diseases, Interstitial; Male; Mutation; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Tomography, X-Ray Computed	2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD). Thorax, 2020, Volume: 75, Issue:2 Topics: Adolescent; Adrenal Cortex Hormones; Azithromycin; Cause of Death; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Infant; Kaplan-Meier Estimate; Longitudinal Studies; Lung Diseases, Interstitial; Male; Monitoring, Physiologic; Prospective Studies; Registries; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors	2020
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Annals of internal medicine, 2020, 06-16, Volume: 172, Issue:12 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Information Dissemination; Mass Media; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2	2020
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging, 2020, Mar-30, Volume: 12, Issue:8 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dipeptidyl Peptidase 4; Humans; Hydroxychloroquine; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Quercetin; Receptors, Virus; SARS-CoV-2	2020
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment. Journal of the American College of Cardiology, 2020, 05-26, Volume: 75, Issue:20 Topics: Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Drug Interactions; Drug Repositioning; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2; Torsades de Pointes	2020
Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review. Infection control and hospital epidemiology, 2020, Volume: 41, Issue:9 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Prospective Studies; SARS-CoV-2	2020
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. American journal of obstetrics & gynecology MFM, 2020, Volume: 2, Issue:2 Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; Cesarean Section; COVID-19; COVID-19 Nucleic Acid Testing; Disease Management; Enzyme Inhibitors; Female; Fluid Therapy; Gestational Age; Hospitalization; Hospitals, Community; Hospitals, University; Humans; Hydroxychloroquine; Infection Control; Intensive Care Units; Labor, Induced; Labor, Obstetric; Multi-Institutional Systems; New York City; Obesity, Maternal; Obstetric Labor, Premature; Oxygen Inhalation Therapy; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2; Telemedicine; Young Adult	2020
Chloroquine as a prophylactic agent against COVID-19? International journal of antimicrobial agents, 2020, Volume: 55, Issue:6 Topics: Animals; Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Pre-Exposure Prophylaxis; SARS-CoV-2; Vero Cells	2020
Does hydroxychloroquine prevent the transmission of COVID-19? Annals of the rheumatic diseases, 2020, Volume: 79, Issue:6 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ritonavir; Sample Size; SARS-CoV-2; United States	2020
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. The Canadian journal of cardiology, 2020, Volume: 36, Issue:6 Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Canada; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; Risk Management; Ritonavir; SARS-CoV-2	2020
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. Heart rhythm, 2020, Volume: 17, Issue:7 Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Contraindications, Drug; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes	2020
Taking the Longer View of COVID-19. The oncologist, 2020, Volume: 25, Issue:6 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection. The journal of allergy and clinical immunology. In practice, 2020, Volume: 8, Issue:6 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Bromhexine; Coronavirus Infections; COVID-19; Cytokines; Expectorants; Humans; Hydroxychloroquine; Hypertension; Inflammation; Interferon beta-1a; Interleukin-1; Interleukin-12; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Obesity; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Risk Factors; Smoking; Tumor Necrosis Factor-alpha	2020
Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Liver; Lung; Pandemics; Piperacillin, Tazobactam Drug Combination; Pneumonia, Viral; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed	2020
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Chicago; Chronic Pain; Coinfection; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Hypertension; Lung; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Streptococcal Infections; Streptococcus pyogenes; Tomography, X-Ray Computed; Treatment Outcome	2020
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Antimalarials; Antirheumatic Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Repositioning; Humans; Hydroxychloroquine; Off-Label Use; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sample Size; SARS-CoV-2; Treatment Outcome; United States	2020
Some drugs for COVID-19. The Medical letter on drugs and therapeutics, 2020, 04-06, Volume: 62, Issue:1595 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Neuraminidase; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Research in social & administrative pharmacy : RSAP, 2021, Volume: 17, Issue:2 Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Drug Therapy, Combination; Humans; Hydroxychloroquine; Long QT Syndrome; Pharmacovigilance; Torsades de Pointes; United States	2021
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospitalization; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Intensive Care Units; Intubation; Male; Middle Aged; New York City; Organ Transplantation; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Steroids; Transplant Recipients; Treatment Outcome; United States	2020
Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin. Journal of the American College of Cardiology, 2020, 06-16, Volume: 75, Issue:23 Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Monitoring; Electrocardiography; Female; Humans; Hydroxychloroquine; Inpatients; Intersectoral Collaboration; Male; Middle Aged; Pandemics; Pneumonia, Viral; Risk Adjustment; SARS-CoV-2; Telemedicine; Treatment Outcome; United States	2020
Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes. Archives of cardiovascular diseases, 2020, Volume: 113, Issue:5 Topics: Azithromycin; Betacoronavirus; Cardiovascular Diseases; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes	2020
Two distinct cases with COVID-19 in kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:8 Topics: Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Calcineurin Inhibitors; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients	2020
Hydroxychloroquine in Covid-19: Does the end justify the means? Current research in translational medicine, 2020, Volume: 68, Issue:3 Topics: Antibody Formation; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunity, Cellular; Immunity, Herd; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Viral Vaccines	2020
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report. Chest, 2020, Volume: 158, Issue:1 Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; C-Reactive Protein; Clinical Deterioration; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Fatal Outcome; Female; Humans; Hydroxychloroquine; Hypoxia; Lymphohistiocytosis, Hemophagocytic; Male; Myocarditis; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Shock, Septic	2020
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microbial pathogenesis, 2020, Volume: 145 Topics: Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Repositioning; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2020
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circulation. Arrhythmia and electrophysiology, 2020, Volume: 13, Issue:6 Topics: Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Electrocardiography; Follow-Up Studies; Humans; Hydroxychloroquine; Incidence; Pandemics; Pneumonia, Viral; Prospective Studies; Risk Factors; SARS-CoV-2; United States	2020
An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19. Swiss medical weekly, 2020, 04-20, Volume: 150 Topics: Adult; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Accuracy; Drug Synergism; Drug Therapy, Combination; France; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2	2020
COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients? British journal of clinical pharmacology, 2020, Volume: 86, Issue:6 Topics: Azithromycin; Chloroquine; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Long QT Syndrome; Mental Disorders; Pandemics; Pneumonia, Viral; Risk Factors	2020
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Revue neurologique, 2020, Volume: 176, Issue:6 Topics: alpha-Glucosidases; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Cardiorespiratory Fitness; Coronavirus Infections; COVID-19; Emergency Treatment; France; Glycogen Storage Disease Type II; Hospitalization; Humans; Hydroxychloroquine; Immune System Diseases; Immunoglobulins, Intravenous; Immunosuppressive Agents; Muscular Atrophy, Spinal; Neuromuscular Diseases; Oligonucleotides; Pandemics; Physical Therapy Modalities; Pneumonia, Viral; Prognosis; RNA, Small Interfering; SARS-CoV-2; Steroids; Withholding Treatment	2020
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine. European journal of clinical investigation, 2020, Volume: 50, Issue:6 Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Cardiotoxicity; Chloroquine; Coronavirus Infections; COVID-19; Dehydration; Drug Interactions; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; Risk Assessment; Water-Electrolyte Imbalance	2020
COVID-19 and Fake News in the Dominican Republic. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Civil Disorders; Coronavirus Infections; COVID-19; Dissent and Disputes; Dominican Republic; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; Politics; Public Health; SARS-CoV-2; Social Media; Trust	2020
Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 05-04, Volume: 192, Issue:18 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10 Topics: Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Progression; Enzyme Inhibitors; Female; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Lung; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome	2020
COVID-19 and toxicity from potential treatments: Panacea or poison. Emergency medicine Australasia : EMA, 2020, Volume: 32, Issue:4 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome	2020
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. British journal of haematology, 2020, Volume: 190, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Disease-Free Survival; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Survival Rate	2020
Audio Interview: Studying Potential Covid-19 Therapies. The New England journal of medicine, 2020, 05-07, Volume: 382, Issue:19 Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Controlled Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2	2020
Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clinical and experimental dermatology, 2020, Volume: 45, Issue:7 Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; C-Reactive Protein; Ceftriaxone; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Erythema Multiforme; Female; Fibrin Fibrinogen Degradation Products; Hospitalization; Humans; Hydroxychloroquine; Lopinavir; Lymphocyte Count; Middle Aged; Ritonavir	2020
Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin. International journal of antimicrobial agents, 2020, Volume: 55, Issue:6 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Lysosomes; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load	2020
Reactivation of COVID-19 pneumonia: A report of two cases. The Journal of infection, 2020, Volume: 81, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Fatal Outcome; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Radiography; SARS-CoV-2; Tomography, X-Ray Computed; Virus Activation; Virus Latency	2020
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA, 2020, 06-23, Volume: 323, Issue:24 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Heart Arrest; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Logistic Models; Male; Middle Aged; New York; Pandemics; Pneumonia, Viral; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Young Adult	2020
Biggest COVID-19 trial tests repurposed drugs first. Nature biotechnology, 2020, Volume: 38, Issue:5 Topics: Adaptive Clinical Trials as Topic; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Standard of Care; United Kingdom	2020
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future oncology (London, England), 2020, Volume: 16, Issue:20 Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Methylprednisolone; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. International journal of antimicrobial agents, 2020, Volume: 56, Issue:2 Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; Drug Synergism; G(M1) Ganglioside; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Spike Glycoprotein, Coronavirus; Thermodynamics; Virus Attachment	2020
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome. Journal of pharmacokinetics and pharmacodynamics, 2020, Volume: 47, Issue:3 Topics: Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Models, Biological; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Viral Load	2020
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart rhythm, 2020, Volume: 17, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Torsades de Pointes	2020
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic. Research in social & administrative pharmacy : RSAP, 2021, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Azithromycin; Chloroquine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Heart Diseases; Humans; Hydroxychloroquine; Male; Middle Aged; Pharmacoepidemiology; Retrospective Studies; Risk Factors; Young Adult	2021
The emergence of methemoglobinemia amidst the COVID-19 pandemic. American journal of hematology, 2020, Volume: 95, Issue:8 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Hydroxychloroquine; Male; Methemoglobinemia; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Acute meningoencephalitis in a patient with COVID-19. Revue neurologique, 2020, Volume: 176, Issue:6 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Male; Meningoencephalitis; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1). Annals of internal medicine, 2020, 07-21, Volume: 173, Issue:2 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2; United States	2020
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:5 Topics: Aged; Antineoplastic Agents, Immunological; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Lung Neoplasms; Melanoma; Multiple Chronic Conditions; Nivolumab; Oseltamivir; Pandemics; Pneumonia, Viral; Programmed Cell Death 1 Receptor; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome	2020
Three Cases of COVID-19 Disease With Colonic Manifestations. The American journal of gastroenterology, 2020, Volume: 115, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Antimalarials; Astringents; Azithromycin; Betacoronavirus; Colitis; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; Radiography, Abdominal; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Zinc Sulfate	2020
Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? Journal of clinical pharmacology, 2020, Volume: 60, Issue:7 Topics: Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2	2020
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. International journal of cardiology, 2020, 10-01, Volume: 316 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Death, Sudden, Cardiac; Drug Monitoring; Electrocardiography; Female; Hospitalization; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
COVID-19 and QT interval prolongation: more than just drug toxicity? Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2020, 10-01, Volume: 22, Issue:10 Topics: Adrenergic beta-Agonists; Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Electrocardiography; Humans; Hydroxychloroquine; Isoproterenol; Long QT Syndrome; Male; Myocarditis; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Troponin I	2020
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database. Circulation, 2020, 07-21, Volume: 142, Issue:3 Topics: Azithromycin; Cardiotoxicity; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Electrocardiography; Heart Diseases; Humans; Hydroxychloroquine; Pharmacovigilance; Public Health Surveillance; World Health Organization	2020
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:12 Topics: Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Female; Humans; Hydroxychloroquine; Incidence; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Spain; Treatment Outcome	2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. The European respiratory journal, 2020, Volume: 56, Issue:1 Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coinfection; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Emigrants and Immigrants; Female; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary	2020
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. American journal of epidemiology, 2020, 11-02, Volume: 189, Issue:11 Topics: Aged; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Outpatients; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring. Journal of the American Heart Association, 2020, 06-16, Volume: 9, Issue:12 Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prognosis; Risk Factors; SARS-CoV-2	2020
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS patient care and STDs, 2020, Volume: 34, Issue:8 Topics: Adult; Antiretroviral Therapy, Highly Active; Azithromycin; Betacoronavirus; CD4 Lymphocyte Count; Cephalosporins; Chicago; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Serologic Tests; Treatment Outcome	2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet (London, England), 2020, 06-20, Volume: 395, Issue:10241 Topics: Aged; Antiviral Agents; Azithromycin; Betacoronavirus; Cause of Death; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Prognosis; Risk Factors; SARS-CoV-2	2020
Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research. International journal of cardiology, 2020, 10-01, Volume: 316 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend. The Journal of infection, 2020, Volume: 81, Issue:2 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Hydroxychloroquine and azithromycin as a treatment of COVID-19. Internal and emergency medicine, 2020, Volume: 15, Issue:5 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; France; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2	2020
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19? Multiple sclerosis and related disorders, 2020, Volume: 42 Topics: Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunologic Factors; Interferon-beta; Length of Stay; Male; Multiple Sclerosis; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed	2020
Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin. Journal of cardiovascular electrophysiology, 2020, Volume: 31, Issue:8 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Pandemics; Patients; SARS-CoV-2; Torsades de Pointes	2020
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nature medicine, 2020, Volume: 26, Issue:6 Topics: Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Electrocardiography; Humans; Hydroxychloroquine; Oxygen; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes; Viral Load	2020
Characteristics of the initial patients hospitalized for COVID-19: a single-center report Turkish journal of medical sciences, 2020, Aug-26, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult	2020
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine. Infectious diseases (London, England), 2020, Volume: 52, Issue:9 Topics: Aged; Azithromycin; Betacoronavirus; Blood Transfusion; Continuous Renal Replacement Therapy; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Enzyme Inhibitors; Glucosephosphate Dehydrogenase Deficiency; Haptoglobins; Hemolysis; Humans; Hydroxychloroquine; Hypoxia; Male; Nasopharynx; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
Covid-19 and lung cancer: A greater fatality rate? Lung cancer (Amsterdam, Netherlands), 2020, Volume: 146 Topics: Aged; Aged, 80 and over; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Cross Infection; Drug Combinations; Female; Humans; Hydroxychloroquine; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prognosis; SARS-CoV-2; Spain	2020
Co-infection with an atypical pathogen of COVID-19 in a young. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Male; Pneumonia, Mycoplasma	2021
The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. Antimicrobial agents and chemotherapy, 2020, 07-22, Volume: 64, Issue:8 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deception; Drug Combinations; France; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Scholarly Communication	2020
Coronavirus disease 2019 in pregnancy: early lessons. American journal of obstetrics & gynecology MFM, 2020, Volume: 2, Issue:2 Topics: Acute Kidney Injury; Adult; Anesthesia, General; Anti-Bacterial Agents; Antihypertensive Agents; Azithromycin; Bronchial Spasm; Carrier State; Ceftriaxone; Cesarean Section; COVID-19; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Fever; Health Personnel; Hospitalization; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Intubation, Intratracheal; Labor, Induced; New York City; Nicardipine; Occupational Exposure; Oxygen Inhalation Therapy; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Infectious; Pregnancy in Diabetics; Respiration, Artificial; SARS-CoV-2; Uterine Inertia	2020
Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2. Archivos de cardiologia de Mexico, 2020, Volume: 90, Issue:Supl Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral	2020
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:5 Topics: Anti-Infective Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Biological Availability; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen-Ion Concentration; Hydroxychloroquine; Lung; Metabolic Clearance Rate; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin. Le infezioni in medicina, 2020, Jun-01, Volume: 28, Issue:suppl 1 Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Azithromycin; Combined Modality Therapy; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Enoxaparin; Humans; Hydroxychloroquine; Hypertension; Male; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Thrombophilia; Tomography, X-Ray Computed; Valsartan	2020
Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy. The AAPS journal, 2020, 06-12, Volume: 22, Issue:4 Topics: Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; Coronavirus Infections; COVID-19; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral	2020
Pharmacist's perspective on HCQ treatment of COVID-19. The Kaohsiung journal of medical sciences, 2020, Volume: 36, Issue:8 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pharmacists; Pneumonia, Viral; SARS-CoV-2	2020
Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient. Thrombosis research, 2020, Volume: 193 Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Antimalarials; Azithromycin; Betacoronavirus; Ceftriaxone; Cerebral Infarction; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma. Journal of the neurological sciences, 2020, 08-15, Volume: 415 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Developing Countries; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Primary Health Care; SARS-CoV-2	2020
A case of COVID-19 infection presenting with a seizure following severe brain edema. Seizure, 2020, Volume: 80 Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Azithromycin; Betacoronavirus; Brain Edema; Brain Infarction; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Decompression, Surgical; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Intracranial Hemorrhages; Lung; Magnetic Resonance Imaging; Male; Nephrosis; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Pregnenediones; SARS-CoV-2; Seizures; Severity of Illness Index; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed	2020
Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Annals of internal medicine, 2020, 07-21, Volume: 173, Issue:2 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States	2020
COVID-19, severe asthma, and biologics. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020, Volume: 125, Issue:3 Topics: Acetates; Adrenergic beta-2 Receptor Antagonists; Amoxicillin-Potassium Clavulanate Combination; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Azithromycin; Betacoronavirus; Budesonide; Convalescence; Coronavirus Infections; COVID-19; Cyclopropanes; Eosinophils; Female; Humans; Hydroxychloroquine; Ipratropium; Male; Middle Aged; Pandemics; Pneumonia, Viral; Quinolines; SARS-CoV-2; Sulfides; Treatment Outcome	2020
Cerebral Venous Thrombosis Associated with COVID-19. AJNR. American journal of neuroradiology, 2020, Volume: 41, Issue:8 Topics: Adult; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Intracranial Thrombosis; Male; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Venous Thrombosis; Young Adult	2020
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2 Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin	2020
Fatal SARS-CoV-2 infection in a renal transplant recipient. CEN case reports, 2020, Volume: 9, Issue:4 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Deterioration; Coronavirus Infections; COVID-19; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Tomography, X-Ray Computed	2020
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. Journal of Korean medical science, 2020, Jun-22, Volume: 35, Issue:24 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Primary Prevention; SARS-CoV-2	2020
COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:5 Topics: Acute Kidney Injury; Adult; Aged; Azithromycin; Calcineurin Inhibitors; COVID-19; COVID-19 Nucleic Acid Testing; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; New York City; Prednisone; Renal Replacement Therapy; Respiration, Artificial; Retrospective Studies; RNA, Viral; SARS-CoV-2; Transplant Recipients; Treatment Outcome	2020
Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6 Topics: Acute Kidney Injury; Ambulatory Care; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azithromycin; COVID-19; Disease Progression; Enzyme Inhibitors; Female; Graft Rejection; Hospitalization; Humans; Hydroxychloroquine; Hypoxia; Immunocompromised Host; Immunosuppressive Agents; Intubation, Intratracheal; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; New York City; Oxygen Inhalation Therapy; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index	2020
COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. Mycoses, 2020, Volume: 63, Issue:8 Topics: Aged; Aged, 80 and over; Azithromycin; Coronavirus Infections; COVID-19; Diabetes Complications; Female; Humans; Hydroxychloroquine; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Nasopharynx; Pakistan; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors	2020
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19. BMJ case reports, 2020, Jun-24, Volume: 13, Issue:6 Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betacoronavirus; Bicarbonates; Ceftriaxone; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Enoxaparin; Enzyme Inhibitors; Fluid Therapy; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Respiration, Artificial; Rhabdomyolysis; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome	2020
QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:5 Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dimensional Measurement Accuracy; Drug Monitoring; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Outcome Assessment, Health Care; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes	2020
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:12 Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Azithromycin; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lupus Erythematosus, Systemic; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Rheumatic Diseases; Ritonavir; SARS-CoV-2; Severity of Illness Index; Spondylarthropathies	2020
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval. Heart rhythm, 2020, Volume: 17, Issue:11 Topics: Anti-Infective Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Child; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Electrocardiography; Female; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Male; New York City; Outcome and Process Assessment, Health Care; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2	2020
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Inpatients; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2	2020
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020. JAMA internal medicine, 2020, 10-01, Volume: 180, Issue:10 Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Databases, Pharmaceutical; Drug Prescriptions; Humans; Hydroxychloroquine; Outpatients; Pandemics; Pneumonia, Viral; Practice Patterns, Physicians'; Pre-Exposure Prophylaxis; Prescription Drug Monitoring Programs; SARS-CoV-2; United States	2020
Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease? Journal of clinical apheresis, 2020, Volume: 35, Issue:4 Topics: Acute Chest Syndrome; Adult; Analgesics; Anemia, Sickle Cell; Antiviral Agents; Azithromycin; Betacoronavirus; Combined Modality Therapy; Contraindications, Procedure; Coronavirus Infections; COVID-19; Erythrocyte Transfusion; Humans; Hydroxychloroquine; Intubation, Intratracheal; Male; Methylprednisolone; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2	2020
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19. Arquivos brasileiros de cardiologia, 2020, Volume: 114, Issue:6 Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; SARS-CoV-2; Torsades de Pointes; Treatment Outcome	2020
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Infection, 2020, Volume: 48, Issue:5 Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Male; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Respiratory Insufficiency; Ritonavir; SARS-CoV-2; Sulfonamides; Treatment Outcome	2020
Covid-19: A systemic disease treated with a wide-ranging approach: A case report. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2020, Jul-03, Volume: 27, Issue:S Pt 1 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Azithromycin; China; Coronavirus Infections; COVID-19; Darunavir; Disease Progression; Enoxaparin; Humans; Hydroxychloroquine; Male; Middle Aged; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Ritonavir	2020
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020, Volume: 59, Issue:2 Topics: Age Distribution; Aged; Aged, 80 and over; Antimalarials; Azithromycin; Chloroquine; Coronavirus Infections; COVID-19; Electrocardiography; Female; Follow-Up Studies; Hospitalization; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Risk Assessment; Sex Distribution; Urban Population	2020
Benefit v. risk when using chloroquine in patients with severe COVID-19 disease. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2020, 04-02, Volume: 110, Issue:5 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Management of crash and burn patients with SARS-CoV-2 associated ARDS. Journal of cardiac surgery, 2020, Volume: 35, Issue:9 Topics: Adult Stem Cells; Angiotensin-Converting Enzyme 2; Azithromycin; Blood Component Transfusion; COVID-19; Extracorporeal Membrane Oxygenation; Humans; Hydroxychloroquine; Ivermectin; Plasma; Recombinant Proteins; Respiratory Distress Syndrome; SARS-CoV-2	2020
Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis. Oncology (Williston Park, N.Y.), 2020, 07-15, Volume: 34, Issue:7 Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Hydroxychloroquine; Mortality; Neoplasms; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2	2020
Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery. BMJ case reports, 2020, Jul-16, Volume: 13, Issue:7 Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Cesarean Section; Coronavirus Infections; COVID-19; Disease Progression; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2; Treatment Outcome	2020
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Heart and vessels, 2021, Volume: 36, Issue:1 Topics: Aged; Anti-Bacterial Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Darunavir; Electrocardiography; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Ritonavir; SARS-CoV-2	2021
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin. Pharmacotherapy, 2020, Volume: 40, Issue:9 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Cardiotoxicity; Cardiovascular Diseases; Child; Child, Preschool; COVID-19 Drug Treatment; Databases, Factual; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Middle Aged; Risk Factors; Sex Factors; Young Adult	2020
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view. Endocrine, 2020, Volume: 70, Issue:1 Topics: Aged; Axitinib; Azithromycin; Betacoronavirus; Carcinoid Tumor; Comorbidity; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Italy; Male; Neuroendocrine Tumors; Pandemics; Pneumonia, Viral; Protein-Tyrosine Kinases; Randomized Controlled Trials as Topic; SARS-CoV-2; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2020
Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data Turkish journal of medical sciences, 2021, 02-26, Volume: 51, Issue:1 Topics: Age Factors; Aged; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Turkey	2021
Risch Responds to "How to Consider Low Reported Death Rates in COVID-19". American journal of epidemiology, 2020, 11-02, Volume: 189, Issue:11 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin? American journal of epidemiology, 2020, 11-02, Volume: 189, Issue:11 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Outpatients; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS". American journal of epidemiology, 2020, 11-02, Volume: 189, Issue:11 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Outpatients; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019. Cardiology in the young, 2020, Volume: 30, Issue:10 Topics: Adolescent; Anti-Infective Agents; Azithromycin; Child; Coronavirus Infections; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Outcome and Process Assessment, Health Care; Pandemics; Pneumonia, Viral; Retrospective Studies; Turkey	2020
Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin. British journal of clinical pharmacology, 2021, Volume: 87, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Repositioning; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Off-Label Use; Patient Discharge; Respiration, Artificial; Retrospective Studies; Treatment Outcome; Young Adult	2021
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature, 2020, Volume: 585, Issue:7826 Topics: Animals; Azithromycin; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; Female; Humans; Hydroxychloroquine; In Vitro Techniques; Kinetics; Macaca fascicularis; Male; Pandemics; Pneumonia, Viral; Pre-Exposure Prophylaxis; Respiratory Mucosa; SARS-CoV-2; Time Factors; Treatment Failure; Vero Cells; Viral Load	2020
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. PloS one, 2020, Volume: 15, Issue:7 Topics: Adult; Aged; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Humans; Hydroxychloroquine; Male; Middle Aged; New York City; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2020
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece. Medicina (Kaunas, Lithuania), 2020, Jul-17, Volume: 56, Issue:7 Topics: Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Coronavirus Infections; COVID-19; Creatinine; Cryoglobulinemia; Cyclophosphamide; Enzyme Inhibitors; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Greece; Humans; Hydroxychloroquine; Immunocompromised Host; Immunologic Factors; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rituximab; SARS-CoV-2; Tomography, X-Ray Computed	2020
Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU Turkish journal of medical sciences, 2021, 04-30, Volume: 51, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Amides; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Early Medical Intervention; Early Warning Score; Female; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Length of Stay; Male; Middle Aged; Prospective Studies; Pyrazines; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult	2021
Diarrhoea: An Atypical Presentation of COVID-19. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6 Topics: Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Diarrhea; Female; Fever; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult	2020
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6 Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2020
CT Scan Findings of Five Mildly Symptomatic COVID Patients from India. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6 Topics: Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; Quarantine; SARS-CoV-2; Tomography, X-Ray Computed; Triage	2020
Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Annals of internal medicine, 2020, 09-01, Volume: 173, Issue:5 Topics: Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States	2020
Description of 3 patients with myasthenia gravis and COVID-19. Journal of the neurological sciences, 2020, 10-15, Volume: 417 Topics: Adult; Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hypertension; Hypothyroidism; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lopinavir; Male; Myasthenia Gravis; Pandemics; Plasmapheresis; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs. Annals of the American Thoracic Society, 2020, Volume: 17, Issue:8 Topics: Azithromycin; Bayes Theorem; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. International journal of antimicrobial agents, 2020, Volume: 56, Issue:3 Topics: Amino Acid Motifs; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Betacoronavirus; Binding Sites; Cathepsin L; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thermodynamics; Viral Nonstructural Proteins; Virus Attachment	2020
Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dust; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic. Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:11 Topics: Anti-Infective Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug-Related Side Effects and Adverse Reactions; Hospitalization; Humans; Hydroxychloroquine; Italy; Outcome Assessment, Health Care; Pandemics; Pneumonia, Viral; SARS-CoV-2; Time-to-Treatment	2020
Searching for COVID-19 treatments: First, do no harm. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 10-30, Volume: 77, Issue:22 Topics: Antiviral Agents; Azithromycin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Evidence-Based Medicine; Hemorrhagic Fever, Ebola; Humans; Hydroxychloroquine; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic	2020
Auditory Cinchonism in COVID Era. Ear, nose, & throat journal, 2020, Volume: 99, Issue:9 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hearing Loss, Sensorineural; Humans; Hydroxychloroquine; Ototoxicity; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tinnitus; Vertigo	2020
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection. Mayo Clinic proceedings, 2020, Volume: 95, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study. Spinal cord series and cases, 2020, 08-04, Volume: 6, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Case-Control Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Prognosis; Rehabilitation Centers; Ritonavir; SARS-CoV-2; Spinal Cord Injuries	2020
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians. Respiration; international review of thoracic diseases, 2020, Volume: 99, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Cannula; Cardiology; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Heparin, Low-Molecular-Weight; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Internal Medicine; Italy; Lung; Middle Aged; Noninvasive Ventilation; Pandemics; Physicians; Pneumonia, Viral; Practice Patterns, Physicians'; Protease Inhibitors; Pulmonary Medicine; Referral and Consultation; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Surveys and Questionnaires; Tomography, X-Ray Computed	2020
SARS CoV-2 infection among patients using immunomodulatory therapies. Annals of the rheumatic diseases, 2021, Volume: 80, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Azithromycin; Biological Products; COVID-19; COVID-19 Drug Treatment; Enzyme Inhibitors; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunomodulation; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intensive Care Units; Janus Kinase Inhibitors; Male; Middle Aged; Respiration, Artificial; Sarcoidosis; SARS-CoV-2; Surveys and Questionnaires; Tumor Necrosis Factor Inhibitors; Young Adult	2021
Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak. British journal of haematology, 2020, Volume: 191, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Azithromycin; Bacterial Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Humans; Hydroxychloroquine; Infection Control; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pandemics; Plasmablastic Lymphoma; Prednisone; Rituximab; SARS-CoV-2; Spain; Superinfection; Vincristine	2020
Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Adult; Aged; Antiviral Agents; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prospective Studies; SARS-CoV-2	2020
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA). European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:15 Topics: Anemia; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
[Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality]. Medicina clinica, 2020, 11-13, Volume: 155, Issue:9 Topics: Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inpatients; Lopinavir; Male; Pandemics; Pneumonia, Viral; Proportional Hazards Models; Retrospective Studies; Ritonavir; SARS-CoV-2; Spain; Treatment Outcome	2020
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study. PloS one, 2020, Volume: 15, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antimalarials; Azithromycin; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Intensive Care Units; Interleukin-6; Kaplan-Meier Estimate; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult	2020
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatology international, 2020, Volume: 40, Issue:10 Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lopinavir; Lung Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sex Factors; Spain	2020
Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy. Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:5 Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lysosomes	2021
SDRIFE-like rash associated with COVID-19, clinicopathological correlation. The Australasian journal of dermatology, 2021, Volume: 62, Issue:1 Topics: Aged; Antiviral Agents; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Drug Eruptions; Exanthema; Female; Humans; Hydroxychloroquine	2021
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island. Journal of global antimicrobial resistance, 2020, Volume: 23 Topics: Adrenal Cortex Hormones; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Reunion; SARS-CoV-2	2020
Melkersson-Rosenthal Syndrome Induced by COVID-19. The American journal of emergency medicine, 2021, Volume: 41 Topics: Adrenal Cortex Hormones; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Hydroxychloroquine; Melkersson-Rosenthal Syndrome; Middle Aged; SARS-CoV-2	2021
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19. Med (New York, N.Y.), 2020, 12-18, Volume: 1, Issue:1 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Retrospective Studies; SARS-CoV-2; United States; Veterans	2020
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 08-01, Volume: 35, Issue:8 Topics: Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Drug Tolerance; Female; France; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Male; Pandemics; Pneumonia, Viral; Renal Dialysis; SARS-CoV-2	2020
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure. BMJ open respiratory research, 2020, Volume: 7, Issue:1 Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azithromycin; Betacoronavirus; Black or African American; Cannula; Comorbidity; Coronavirus Infections; COVID-19; Diabetes Mellitus; Female; Healthcare-Associated Pneumonia; Heart Diseases; Hispanic or Latino; Humans; Hydroxychloroquine; Hypertension; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Intubation, Intratracheal; Lung Diseases; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Philadelphia; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulse Therapy, Drug; Renal Insufficiency, Chronic; Respiratory Insufficiency; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Smoking; White People	2020
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19. International journal of antimicrobial agents, 2020, Volume: 56, Issue:4 Topics: Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Humans; Hydroxychloroquine; Intensive Care Units; Long QT Syndrome; Lopinavir; Lymphocytes; Male; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Proportional Hazards Models; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome; Troponin I	2020
Neutropenic fever in COVID-19 in kidney transplant patient. Reviews in medical virology, 2021, Volume: 31, Issue:1 Topics: Adult; Azithromycin; Cefepime; COVID-19; COVID-19 Drug Treatment; Febrile Neutropenia; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Kidney Transplantation; SARS-CoV-2; Transplant Recipients	2021
Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19. American journal of epidemiology, 2021, 04-06, Volume: 190, Issue:4 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Outpatients; Pandemics; SARS-CoV-2; Treatment Outcome	2021
Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic. Mayo Clinic proceedings, 2020, Volume: 95, Issue:9 Topics: Azithromycin; Betacoronavirus; Bias; Cognitive Science; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. International journal of antimicrobial agents, 2020, Volume: 56, Issue:2 Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Synergism; Drug Therapy, Combination; G(M1) Ganglioside; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Molecular Dynamics Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Domains; SARS-CoV-2; Sequence Alignment; Spike Glycoprotein, Coronavirus; Virus Attachment	2020
Reply to: "QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights". Journal of cardiovascular electrophysiology, 2020, Volume: 31, Issue:10 Topics: Arrhythmias, Cardiac; Azithromycin; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pharmacogenetics; SARS-CoV-2	2020
QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights. Journal of cardiovascular electrophysiology, 2020, Volume: 31, Issue:10 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; Incidence; Long QT Syndrome; Pandemics; Pharmacogenetics; SARS-CoV-2	2020
Viral exanthema as manifestation of SARS-CoV-2 infection: A case report. Medicine, 2020, Aug-28, Volume: 99, Issue:35 Topics: Administration, Topical; Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Exanthema; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Symptom Assessment; Treatment Outcome	2020
Urticarial vasculitis in a COVID-19 recovered patient. International journal of dermatology, 2020, Volume: 59, Issue:10 Topics: Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Histamine Antagonists; Humans; Hydroxychloroquine; Middle Aged; Recurrence; SARS-CoV-2; Skin; Treatment Outcome; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous	2020
Coronavirus disease 2019 infection in patients with recent cardiac surgery: does chronic anticoagulant therapy have a protective effect? Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:10 Topics: Aged; Anti-Infective Agents; Anticoagulants; Azithromycin; Cardiac Surgical Procedures; Combined Modality Therapy; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Male; Outcome and Process Assessment, Health Care; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Postoperative Complications; Tomography, X-Ray Computed	2020
Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach. Toxicology and applied pharmacology, 2020, 11-01, Volume: 406 Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Mining; Databases, Genetic; Drug Therapy, Combination; Gene Regulatory Networks; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Toxicogenetics	2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. Oncoimmunology, 2020, 07-08, Volume: 9, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Cell Line, Tumor; Cisplatin; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; Crizotinib; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; France; Humans; Hydroxychloroquine; Mice; Neoplasms; Oxaliplatin; Programmed Cell Death 1 Receptor; SARS-CoV-2	2020
Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19. Clinical and translational science, 2020, Volume: 13, Issue:6 Topics: Aged; Aged, 80 and over; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2	2020
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. Journal of medical microbiology, 2020, Volume: 69, Issue:10 Topics: Azithromycin; Betacoronavirus; Cell Membrane Permeability; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Hospitalization; Humans; Hydroxychloroquine; Ionophores; Length of Stay; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Zinc Sulfate	2020
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA cardiology, 2020, Sep-01, Volume: 5, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2	2020
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation. JAMA cardiology, 2020, 09-01, Volume: 5, Issue:9 Topics: Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Intensive Care Units; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA cardiology, 2020, Sep-01, Volume: 5, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2	2020
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis. BMJ open, 2020, 09-17, Volume: 10, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Double-Blind Method; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Registries; Ritonavir; SARS-CoV-2; Single-Blind Method; Stem Cell Transplantation	2020
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen. International journal of cardiology, 2021, 02-01, Volume: 324 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Patient Safety; Retrospective Studies	2021
Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection. British journal of haematology, 2020, Volume: 191, Issue:2 Topics: Adrenal Cortex Hormones; Anticoagulants; Azithromycin; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; Delayed Diagnosis; Diagnostic Errors; Erythrocyte Transfusion; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Osteonecrosis; Oxygen Inhalation Therapy; Rheumatic Fever; SARS-CoV-2; Sickle Cell Trait; Splenectomy; Superinfection; Tachycardia; Thrombocytopenia; Young Adult	2020
COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus. International journal of dermatology, 2020, Volume: 59, Issue:11 Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiphospholipid Syndrome; Antirheumatic Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Dermatologic Agents; Female; Hidradenitis Suppurativa; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; SARS-CoV-2	2020
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports. Drug safety, 2020, Volume: 43, Issue:12 Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting	2020
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Azithromycin; COVID-19; Drug Therapy, Combination; Hospitalization; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Azithromycin; COVID-19; Drug Therapy, Combination; Hospitalization; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. European journal of clinical investigation, 2021, Volume: 51, Issue:1 Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azithromycin; Bacteremia; Candidemia; COVID-19 Drug Treatment; Enzyme Inhibitors; Female; Gram-Negative Bacterial Infections; Humans; Hydroxychloroquine; Italy; Klebsiella Infections; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Ventilator-Associated; Protective Factors; Pseudomonas Infections; Respiration, Artificial; SARS-CoV-2; Staphylococcal Infections; Superinfection; Teicoplanin	2021
Revisiting the cardiovascular risk of hydroxychloroquine in RA. Nature reviews. Rheumatology, 2020, Volume: 16, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Arthritis, Rheumatoid; Azithromycin; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Heart Disease Risk Factors; Humans; Hydroxychloroquine; Safety; SARS-CoV-2; Sulfasalazine; Time Factors	2020
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era. Circulation. Arrhythmia and electrophysiology, 2020, Volume: 13, Issue:11 Topics: Action Potentials; Adolescent; Adult; Aged; Antiviral Agents; Azithromycin; Cardiotoxicity; COVID-19; COVID-19 Drug Treatment; Delivery of Health Care; Female; Heart Conduction System; Heart Rate; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; New York; Patient Safety; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Torsades de Pointes; Treatment Outcome; Young Adult	2020
Azithromycin in patients with COVID-19: Friend or foe? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Sudden Cardiac Death in Haemodialysis Patients under Hydroxychloroquine Treatment for COVID-19: A Report of Two Cases. Blood purification, 2021, Volume: 50, Issue:3 Topics: Aged; Aged, 80 and over; Azithromycin; COVID-19; COVID-19 Drug Treatment; Death, Sudden, Cardiac; Drug Synergism; Drug Therapy, Combination; Fatal Outcome; Female; Heart Conduction System; Heparin; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Magnesium; Male; Potassium; Renal Dialysis; SARS-CoV-2	2021
Rapidly rising methemoglobinemia in a patient with severe COVID-19 treated successfully with red cell exchange transfusion. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2021, Volume: 25, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; COVID-19; Erythrocyte Transfusion; Humans; Hydroxychloroquine; Male; Methemoglobinemia; Middle Aged; Respiration, Artificial; SARS-CoV-2; Treatment Outcome	2021
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19. Cardiology in the young, 2021, Volume: 31, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome	2021
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:1 Topics: Aged; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Liver; Male; Middle Aged; Pregnenediones; SARS-CoV-2; Tokyo	2021
Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy. Journal of perinatal medicine, 2020, Nov-26, Volume: 48, Issue:9 Topics: Abnormalities, Drug-Induced; Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Congenital Abnormalities; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Prescriptions; Female; Gestational Age; Humans; Hydroxychloroquine; Italy; Lactation; Maternal-Fetal Exchange; Middle Aged; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2; Teratology	2020
The first wave of COVID-19 in Malta; a national cross-sectional study. PloS one, 2020, Volume: 15, Issue:10 Topics: Adult; Aged; Antiviral Agents; Azithromycin; Coronavirus Infections; COVID-19; Drug Utilization; Female; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Length of Stay; Male; Malta; Middle Aged; Pandemics; Pneumonia, Viral; Survival Analysis	2020
QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study. International journal of clinical practice, 2021, Volume: 75, Issue:3 Topics: Aged; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; SARS-CoV-2	2021
Experience in the management of severe COVID-19 patients in an intensive care unit. Cirugia y cirujanos, 2020, Volume: 88, Issue:5 Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Combined Modality Therapy; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospital Mortality; Hospitals, University; Humans; Hydroxychloroquine; Intensive Care Units; Male; Mexico; Middle Aged; Organ Dysfunction Scores; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Symptom Assessment	2020
Community use of antibiotics during the COVID-19 lockdown. Infectious diseases (London, England), 2021, Volume: 53, Issue:2 Topics: Adenoviridae; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Fluoroquinolones; Humans; Hydroxychloroquine; Incidence; Influenza A virus; Influenza B virus; Influenza, Human; Italy; Macrolides; Pandemics; Penicillins; Physical Distancing; Prescription Drug Overuse; Quarantine; Respiratory Syncytial Viruses; Respiratory Tract Infections; SARS-CoV-2	2021
Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan. Journal of patient safety, 2021, 01-01, Volume: 17, Issue:1 Topics: Azithromycin; COVID-19; Delivery of Health Care; Humans; Hydroxychloroquine; Pandemics; SARS-CoV-2; Taiwan	2021
Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients. Revista espanola de cardiologia (English ed.), 2021, Volume: 74, Issue:1 Topics: Aged; Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2	2021
QT Interval in Patients With COVID-19. JAMA cardiology, 2021, 03-01, Volume: 6, Issue:3 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
QT Interval in Patients With COVID-19. JAMA cardiology, 2021, 03-01, Volume: 6, Issue:3 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
QT Interval in Patients With COVID-19-Reply. JAMA cardiology, 2021, 03-01, Volume: 6, Issue:3 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Has the door closed on hydroxychloroquine for SARS-COV-2? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1 Topics: Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Cardiotoxicity; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2; Treatment Outcome	2021
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19. Biochemical and biophysical research communications, 2021, 01-29, Volume: 538 Topics: Angiotensin-Converting Enzyme 2; Antibodies, Neutralizing; Azithromycin; Binding Sites; COVID-19; COVID-19 Vaccines; Gangliosides; Humans; Hydroxychloroquine; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2021
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation. Chemico-biological interactions, 2020, Dec-01, Volume: 332 Topics: Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; HSP90 Heat-Shock Proteins; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Protein Interaction Maps; Proto-Oncogene Proteins c-akt; SARS-CoV-2; Signal Transduction	2020
The first cancer patient with COVID-19 in Slovakia. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2020,Spring, Volume: 33, Issue:5 Topics: Adenocarcinoma; Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Male; Pandemics; Patient Discharge; Pneumonia, Viral; SARS-CoV-2; Slovakia; Stomach Neoplasms; Treatment Outcome	2020
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study. International journal of antimicrobial agents, 2020, Volume: 56, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Outpatients; Retrospective Studies; SARS-CoV-2; Young Adult; Zinc	2020
Does hydroxychloroquine reduce mortality for COVID-19? European journal of internal medicine, 2020, Volume: 82 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; Italy; SARS-CoV-2	2020
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:6 Topics: Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 102 Topics: Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Influenza, Human; Long QT Syndrome; Male; Middle Aged; Oseltamivir; SARS-CoV-2	2021
COVID-19 and antimalarials. Have we been doing it wrong all along? European journal of pharmacology, 2021, Jan-15, Volume: 891 Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Drug Repositioning; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study. Journal of medical Internet research, 2020, 11-20, Volume: 22, Issue:11 Topics: Adenosine Monophosphate; Alanine; Azithromycin; Chloroquine; Communication; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Federal Government; Fraud; Humans; Hydroxychloroquine; Internet; Language; Mass Media; Pandemics; Pneumonia, Viral; Public Health; United States	2020
Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19. Bratislavske lekarske listy, 2020, Volume: 121, Issue:11 Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2	2020
Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:6 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients. Journal of the Chinese Medical Association : JCMA, 2021, 02-01, Volume: 84, Issue:2 Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Viral Load	2021
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease. Cardiology in the young, 2021, Volume: 31, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed	2021
Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. International journal of antimicrobial agents, 2020, Volume: 56, Issue:6 Topics: Aged; Aged, 80 and over; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Long-Term Care; Male; Middle Aged; Nursing Homes; SARS-CoV-2; Time Factors	2020
Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City. Journal of the American Heart Association, 2020, Volume: 9, Issue:23 Topics: Academic Medical Centers; Adult; Aged; Azithromycin; Cohort Studies; COVID-19; Female; Genetic Diseases, Inborn; Heart Defects, Congenital; Hospitalization; Humans; Hydroxychloroquine; Intubation, Intratracheal; Male; New York City; Oxygen Inhalation Therapy; Retrospective Studies; Severity of Illness Index; Young Adult	2020
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI insight, 2021, 01-11, Volume: 6, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Biomarkers; Calgranulin B; Case-Control Studies; Chemokine CCL2; Chemokine CXCL9; COVID-19; Enzyme Inhibitors; Female; Ferritins; Gene Expression Profiling; Humans; Hydroxychloroquine; Immunologic Factors; Interferon Type I; Interferon-gamma; Interleukin-1 Receptor-Like 1 Protein; Interleukin-10; Interleukin-15; Interleukin-2; Interleukin-6; Lactoferrin; Lipocalin-2; Male; Matrix Metalloproteinase 9; Middle Aged; Multivariate Analysis; NF-kappa B; Prognosis; Receptors, Tumor Necrosis Factor, Type I; SARS-CoV-2; Severity of Illness Index; Vascular Endothelial Growth Factor Receptor-1	2021
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital. European journal of hospital pharmacy : science and practice, 2021, Volume: 28, Issue:5 Topics: Adult; Aged; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Drug Prescriptions; Female; France; Hospitals, Teaching; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Pandemics; Patient Safety; Pharmacists; Physicians; Retrospective Studies; Ritonavir	2021
COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases. Infectious disorders drug targets, 2021, Volume: 21, Issue:6 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
COVID-19 mortality risk factors in older people in a long-term care center. European geriatric medicine, 2021, Volume: 12, Issue:3 Topics: Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Long-Term Care; Male; Nursing Homes; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2	2021
It is time to drop hydroxychloroquine from our COVID-19 armamentarium. Medical hypotheses, 2020, Volume: 144 Topics: Animals; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Bradycardia; COVID-19 Drug Treatment; Death, Sudden, Cardiac; Drug Interactions; Heart; Heart Failure; Humans; Hydroxychloroquine; Interferon Type I; Mice; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk; SARS-CoV-2	2020
Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Age Factors; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Bias; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Intensive Care Units; Observational Studies as Topic; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Uncertainty	2021
Hydroxychloroquine with or without Azithromycin in Covid-19. The New England journal of medicine, 2021, 01-14, Volume: 384, Issue:2 Topics: Azithromycin; COVID-19 Drug Treatment; Hospitalization; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Hydroxychloroquine with or without Azithromycin in Covid-19. The New England journal of medicine, 2021, 01-14, Volume: 384, Issue:2 Topics: Azithromycin; COVID-19 Drug Treatment; Hospitalization; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply. The New England journal of medicine, 2021, 01-14, Volume: 384, Issue:2 Topics: Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Hospitalization; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood advances, 2020, 12-08, Volume: 4, Issue:23 Topics: Adolescent; Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Hematologic Neoplasms; Humans; Hydroxychloroquine; Male; Middle Aged; Prognosis; Registries; SARS-CoV-2; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult	2020
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19. International journal of clinical practice, 2021, Volume: 75, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Comorbidity; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; SARS-CoV-2	2021
Electrocardiogrammes d´un patient COVID-19 traité par l´association hydroxychloroquine et azithromycine. The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2 Topics: Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Humans; Hydroxychloroquine; Male	2020
Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Young Adult	2020
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients. Scientific reports, 2020, 12-08, Volume: 10, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Critical Illness; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Potassium; Protease Inhibitors; Risk Factors; SARS-CoV-2; Ventricular Fibrillation; Young Adult	2020
A case of severe course of COVID-19 treated with experimental therapy. Casopis lekaru ceskych, 2020,Summer, Volume: 159, Issue:5 Topics: Aged; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; SARS-CoV-2; Therapies, Investigational	2020
Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series. Respiration; international review of thoracic diseases, 2020, Volume: 99, Issue:12 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; APACHE; Azithromycin; COVID-19; COVID-19 Drug Treatment; Doxycycline; Enzyme Inhibitors; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Length of Stay; Lopinavir; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult	2020
Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'. International journal of antimicrobial agents, 2021, Volume: 57, Issue:2 Topics: Azithromycin; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report. Journal of medical case reports, 2020, Dec-18, Volume: 14, Issue:1 Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Asymptomatic Infections; Azithromycin; C-Reactive Protein; Coombs Test; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin-6; Platelet Aggregation Inhibitors; Prednisolone; SARS-CoV-2; ST Elevation Myocardial Infarction	2020
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 104 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Young Adult	2021
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Drug Repositioning; Drug Synergism; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Monitoring, Physiologic; Patient Safety; RNA, Viral; SARS-CoV-2; Treatment Outcome	2021
Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; SARS-CoV-2; Viral Load	2021
Can we use hydroxychloroquine to treat COVID-19 now? International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Indoles; Interferon-alpha; Lopinavir; Ritonavir; SARS-CoV-2; Uncertainty	2021
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Hydroxychloroquine; SARS-CoV-2; Statistics as Topic; Treatment Outcome	2021
Doxycycline as an Alternative to Azithromycin in Elderly Patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Doxycycline; Drug Combinations; Drug Repositioning; Drug Substitution; Drug Synergism; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Politics; SARS-CoV-2; Uncertainty	2021
Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; SARS-CoV-2; Uncertainty	2021
Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; SARS-CoV-2; Uncertainty	2021
Hydroxychloroquine (HCQ): real treatment or false hope? International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Antiviral Agents; Azithromycin; Controlled Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2; Viral Load	2021
Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; SARS-CoV-2; Uncertainty	2021
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Drug Repositioning; Drug Synergism; Electrocardiography; Humans; Hydroxychloroquine; Hyperkalemia; Hypokalemia; Long QT Syndrome; SARS-CoV-2	2021
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; SARS-CoV-2; Statistics as Topic; Uncertainty	2021
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Hydroxychloroquine; Nasopharynx; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Treatment Outcome; Viral Load	2021
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Antiviral Agents; Azithromycin; COVID-19; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Advanced statistical methods and designs for clinical trials for COVID-19. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Hydroxychloroquine; SARS-CoV-2; Statistics as Topic	2021
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. International journal of antimicrobial agents, 2021, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Drug Repositioning; Drug Synergism; Electrocardiography; Humans; Hydroxychloroquine; Hyperkalemia; Hypokalemia; Long QT Syndrome; Magnesium; Patient Safety; RNA, Viral; SARS-CoV-2; Treatment Outcome	2021
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response. Cell death & disease, 2021, 01-06, Volume: 12, Issue:1 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Chloroquine; Humans; Hydroxychloroquine; Mice	2021
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:6 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Azithromycin; Ceftriaxone; Coinfection; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Dexamethasone; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pneumococcal Infections; SARS-CoV-2; Streptococcus pneumoniae	2021
Azithromycin, a questionable treatment for COVID-19. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lopinavir; Methylprednisolone; Ritonavir; SARS-CoV-2	2021
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19. JACC. Clinical electrophysiology, 2021, Volume: 7, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Body Mass Index; Comorbidity; COVID-19; COVID-19 Drug Treatment; Creatinine; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Female; Heart Failure; Hospitalization; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Mortality; Proportional Hazards Models; Risk Factors; SARS-CoV-2; Troponin I	2021
Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. Toxicological sciences : an official journal of the Society of Toxicology, 2021, 04-12, Volume: 180, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Cardiotoxicity; Chloroquine; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Myocytes, Cardiac; Risk Assessment; SARS-CoV-2; United States	2021
A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic. Journal of molecular graphics & modelling, 2021, Volume: 104 Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Azithromycin; Binding Sites; Boron Compounds; COVID-19; COVID-19 Drug Treatment; Drug Delivery Systems; Drug Dosage Calculations; Humans; Hydroxychloroquine; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Nanomedicine; Nanostructures; Nitrogen Oxides; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Quantum Theory; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thermodynamics	2021
[Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:2 Topics: Aged, 80 and over; Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Physical Functional Performance; Polypharmacy; Retrospective Studies; Risk Factors; Treatment Outcome	2021
Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. International journal of cardiology, 2021, 05-15, Volume: 331 Topics: Adult; Arrhythmias, Cardiac; Artificial Intelligence; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Pandemics	2021
Treatment of COVID-19 in Pregnancy with Hydroxychloroquine and Azithromycin: a case report. Acta bio-medica : Atenei Parmensis, 2020, 07-16, Volume: 91, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Middle Aged; Pregnancy; Pregnancy Complications, Infectious	2020
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196 Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines	2021
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions. The American journal of emergency medicine, 2021, Volume: 48 Topics: Angiotensin-Converting Enzyme 2; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Cardiovascular Diseases; Chloroquine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Humans; Hydroxychloroquine; Long QT Syndrome; Myocytes, Cardiac; Receptors, Coronavirus; SARS-CoV-2; Torsades de Pointes	2021
Hydroxychloroquine in Hospitalized Patients with Covid-19. The New England journal of medicine, 2021, 03-04, Volume: 384, Issue:9 Topics: Azithromycin; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply. The New England journal of medicine, 2021, 03-04, Volume: 384, Issue:9 Topics: Azithromycin; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19. PloS one, 2021, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Middle Aged; SARS-CoV-2; Viral Load	2021
Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study. PloS one, 2021, Volume: 16, Issue:2 Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 1; Female; Hospital Mortality; Hospitals; Humans; Hydroxychloroquine; Length of Stay; Male; Mexico; Middle Aged; Obesity; Oseltamivir; Retrospective Studies; SARS-CoV-2; Sex Factors	2021
Multidrug treatment for COVID-19. Drug discoveries & therapeutics, 2021, Mar-10, Volume: 15, Issue:1 Topics: Azithromycin; COVID-19 Drug Treatment; Doxycycline; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxychloroquine; Ivermectin; Treatment Outcome	2021
The epidemiological and clinical profile of COVID-19 in children: Moroccan experience of the Cheikh Khalifa University Center. The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2 Topics: Adolescent; Azithromycin; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Female; Humans; Hydroxychloroquine; Male; Morocco; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2020
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region. Pathogens and global health, 2021, Volume: 115, Issue:4 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Colchicine; COVID-19; Drug Therapy, Combination; Female; Greece; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult	2021
Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma. PloS one, 2021, Volume: 16, Issue:3 Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Blood Specimen Collection; Chloroquine; Chromatography, High Pressure Liquid; Drug Monitoring; Edetic Acid; Humans; Hydroxychloroquine; Limit of Detection; Tandem Mass Spectrometry	2021
COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels. The Journal of pharmacology and experimental therapeutics, 2021, Volume: 377, Issue:2 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; ERG1 Potassium Channel; HEK293 Cells; Humans; Hydroxychloroquine; Potassium Channel Blockers	2021
Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients. Cardiovascular therapeutics, 2021, Volume: 2021 Topics: Adult; Aged; Arrhythmias, Cardiac; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; SARS-CoV-2	2021
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Hydroxychloroquine + azithromycin treatment in elderly patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:4 Topics: Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Frail Elderly; Humans; Hydroxychloroquine; Nursing Homes; SARS-CoV-2	2021
Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:4 Topics: Aged; Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. PloS one, 2021, Volume: 16, Issue:3 Topics: Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Data Management; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Pandemics; SARS-CoV-2	2021
Can use of hydroxychloroquine and azithromycin as a treatment of COVID-19 affect aquatic wildlife? A study conducted with neotropical tadpole. The Science of the total environment, 2021, Aug-01, Volume: 780 Topics: Animals; Animals, Wild; Anura; Azithromycin; COVID-19 Drug Treatment; Humans; Hydrogen Peroxide; Hydroxychloroquine; Larva; Molecular Docking Simulation; SARS-CoV-2	2021
In vitro safety "clinical trial" of the cardiac liability of drug polytherapy. Clinical and translational science, 2021, Volume: 14, Issue:3 Topics: Arrhythmias, Cardiac; Azithromycin; Cardiotoxicity; Clinical Trials as Topic; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2	2021
Prolonged QT predicts prognosis in COVID-19. Pacing and clinical electrophysiology : PACE, 2021, Volume: 44, Issue:5 Topics: Azithromycin; COVID-19; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Prognosis; SARS-CoV-2	2021
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. JAMA network open, 2021, 04-01, Volume: 4, Issue:4 Topics: Aged, 80 and over; Anti-Infective Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Therapy, Combination; Electrocardiography; Female; Hospitalization; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; New York; Outcome and Process Assessment, Health Care; Risk Factors; SARS-CoV-2; Time Factors	2021
Disputes over the production and dissemination of misinformation in the time of COVID-19. Respiratory medicine, 2021, Volume: 182 Topics: Azithromycin; Communication; COVID-19 Drug Treatment; Dissent and Disputes; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase. European journal of clinical pharmacology, 2021, Volume: 77, Issue:10 Topics: Adult; Aged; Azithromycin; Chloroquine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pharmacovigilance; Retrospective Studies; Torsades de Pointes	2021
The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2021, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; COVID-19 Drug Treatment; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Female; Heart Ventricles; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ (Clinical research ed.), 2021, 05-11, Volume: 373 Topics: Administrative Claims, Healthcare; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Chemotherapy, Adjuvant; Child; Child, Preschool; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Electronic Health Records; Enoxaparin; Female; Fluoroquinolones; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Inpatients; Lopinavir; Male; Middle Aged; Republic of Korea; Ritonavir; Safety; SARS-CoV-2; Spain; Treatment Outcome; United States; Vitamin D; Young Adult	2021
Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021, 07-18, Volume: 23, Issue:7 Topics: Azithromycin; COVID-19 Drug Treatment; Death, Sudden, Cardiac; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2	2021
A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic. Clinical trials (London, England), 2021, Volume: 18, Issue:4 Topics: Ambulatory Care; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; COVID-19 Drug Treatment; Enzyme Inhibitors; Humans; Hydroxychloroquine; Patient Selection; Randomized Controlled Trials as Topic; Risk Assessment; SARS-CoV-2; Telemedicine; United States; United States Department of Veterans Affairs; Veterans	2021
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic. JAMA network open, 2021, 05-03, Volume: 4, Issue:5 Topics: Adenosine Monophosphate; Adult; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Azithromycin; California; Colchicine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Drug Utilization Review; Female; Hospitalization; Humans; Hydrocortisone; Hydroxychloroquine; Male; Pandemics; SARS-CoV-2	2021
Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PloS one, 2021, Volume: 16, Issue:5 Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Brazil; COVID-19; COVID-19 Drug Treatment; Creatinine; Female; Glomerular Filtration Rate; Humans; Hydroxychloroquine; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Vasodilator Agents; Young Adult	2021
How to face COVID-19: proposed treatments based on remdesivir and hydroxychloroquine in the presence of zinc sulfate. Docking/DFT/POM structural analysis. Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:19 Topics: Antiviral Agents; Azithromycin; COVID-19; Humans; Hydroxychloroquine; Molecular Docking Simulation; Zinc Sulfate	2022
QT interval prolongation in geriatric patients treated for SARS-COV-2 infection: OCTA-COVID study. Medicina clinica, 2021, 10-22, Volume: 157, Issue:8 Topics: Aged; Azithromycin; COVID-19; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2	2021
Management of COVID-19 pneumonia in a child with NEMO deficiency. Immunologic research, 2021, Volume: 69, Issue:4 Topics: Amides; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Serotherapy; Ectodermal Dysplasia; Genetic Diseases, X-Linked; Humans; Hydroxychloroquine; I-kappa B Kinase; Immunization, Passive; Male; Primary Immunodeficiency Diseases; Pyrazines; SARS-CoV-2	2021
Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. Medicine, 2021, May-14, Volume: 100, Issue:19 Topics: Aged; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Azithromycin; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Illness; Cytokine Release Syndrome; Humans; Hydroxychloroquine; Interleukin-6; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; RNA, Viral; SARS-CoV-2	2021
Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study. PloS one, 2021, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Survival Rate; Treatment Outcome	2021
Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans. American journal of epidemiology, 2021, 11-02, Volume: 190, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Intention to Treat Analysis; Machine Learning; Male; Middle Aged; Pharmacoepidemiology; Retrospective Studies; SARS-CoV-2; Treatment Outcome; United States; Veterans	2021
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy. PloS one, 2021, Volume: 16, Issue:6 Topics: Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes	2021
Drug-induced QTc interval prolongation in PCR-positive non-ICU COVID-19 patients with diverse findings on chest computed tomography. International journal of clinical practice, 2021, Volume: 75, Issue:10 Topics: Adult; Azithromycin; COVID-19; Electrocardiography; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pharmaceutical Preparations; Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Tomography; Tomography, X-Ray Computed	2021
QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients. Global heart, 2021, 06-08, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Feasibility Studies; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Middle Aged; Point-of-Care Systems; Prospective Studies; Reproducibility of Results; Ritonavir; SARS-CoV-2	2021
Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges. Current drug safety, 2022, Volume: 17, Issue:2 Topics: Adult; Aged; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; SARS-CoV-2	2022
Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19. The European respiratory journal, 2022, Volume: 59, Issue:1 Topics: Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; SARS-CoV-2	2022
QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine. Journal of cardiovascular medicine (Hagerstown, Md.), 2022, 01-01, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Risk Factors	2022
Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish. The Science of the total environment, 2021, Oct-10, Volume: 790 Topics: Animals; Azithromycin; COVID-19 Drug Treatment; Ecosystem; Humans; Hydroxychloroquine; Molecular Docking Simulation; Pandemics; SARS-CoV-2; Zebrafish	2021
[Chronic inflammatory bowel diseases: what happens when SARS-CoV-2 occurs? Preliminary results from a study conducted at the Hassan II University Teaching Hospital in Fes, Morocco (a case report)]. The Pan African medical journal, 2021, Volume: 38 Topics: Adult; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Hospitals, University; Humans; Hydroxychloroquine; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Middle Aged; Morocco	2021
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave. Journal of medical virology, 2022, Volume: 94, Issue:1 Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey	2022
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022, 02-23, Volume: 39, Issue:1 Topics: Adult; Amides; Azithromycin; Child; COVID-19; Hematologic Neoplasms; Humans; Hydroxychloroquine; Pyrazines; SARS-CoV-2; Turkey	2022
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients. Reviews in cardiovascular medicine, 2021, 09-24, Volume: 22, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Early Medical Intervention; Female; France; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Outpatients; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Young Adult	2021
COVID-19 Outbreak in Italy: Report on the First 124 Consecutive Patients Treated at Home. The Tohoku journal of experimental medicine, 2021, Volume: 255, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Cobicistat; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Darunavir; Disease Outbreaks; Drug Combinations; Female; Home Care Services; Hospitalization; Humans; Hydroxychloroquine; Italy; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Telemedicine; Young Adult	2021
Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients. Journal of infection and public health, 2021, Volume: 14, Issue:11 Topics: Azithromycin; Cardiotoxicity; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Retrospective Studies; SARS-CoV-2	2021
'I hope you die': how the COVID pandemic unleashed attacks on scientists. Nature, 2021, Volume: 598, Issue:7880 Topics: Azithromycin; Bullying; Communication; COVID-19; Female; Health Policy; Humans; Hydroxychloroquine; Ivermectin; Male; Pandemics; Politics; Research Personnel; Violence	2021
Keeping Meta-Analyses Hygienic During the COVID-19 Pandemic. Frontiers in public health, 2021, Volume: 9 Topics: Azithromycin; COVID-19; Humans; Hydroxychloroquine; Meta-Analysis as Topic; Pandemics	2021
Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance. Journal of clinical pharmacology, 2022, Volume: 62, Issue:5 Topics: Azithromycin; COVID-19 Drug Treatment; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Pharmacovigilance; Ritonavir	2022
The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019. Revista da Associacao Medica Brasileira (1992), 2021, Volume: 67, Issue:7 Topics: Azithromycin; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Humans; Hydroxychloroquine; Retrospective Studies; SARS-CoV-2	2021
Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. British journal of pharmacology, 2022, Volume: 179, Issue:11 Topics: Acidosis; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Hypokalemia; Induced Pluripotent Stem Cells; SARS-CoV-2	2022
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral research, 2022, Volume: 197 Topics: Animals; Anti-Infective Agents; Azithromycin; Bronchi; Chlorocebus aethiops; COVID-19 Drug Treatment; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lung; Mesocricetus; Middle Aged; Plasma; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Vero Cells	2022
Outpatient prescription patterns of COVID-19 drugs in the metropolitan area of Mexico City. Family practice, 2022, 05-28, Volume: 39, Issue:3 Topics: Adult; Azithromycin; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Prescriptions; Female; Humans; Hydroxychloroquine; Male; Mexico; Outpatients; Pandemics; SARS-CoV-2	2022
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates. Frontiers in bioscience (Landmark edition), 2021, 12-30, Volume: 26, Issue:12 Topics: Azithromycin; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2	2021
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases. Scientific reports, 2022, 01-20, Volume: 12, Issue:1 Topics: Animals; Antibodies, Monoclonal, Humanized; Arrhythmias, Cardiac; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Guinea Pigs; Humans; Hydroxychloroquine; Inflammation; Interleukin-6; Male; SARS-CoV-2	2022
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020. PloS one, 2022, Volume: 17, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Croatia; Databases, Factual; Drug Therapy, Combination; Drug Utilization; Hospitalization; Humans; Hydroxychloroquine; Pandemics; Practice Patterns, Physicians'; SARS-CoV-2	2022
Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study. BMJ open, 2022, 02-09, Volume: 12, Issue:2 Topics: Azithromycin; Cohort Studies; COVID-19 Drug Treatment; Electrocardiography; Humans; Hydroxychloroquine; Retrospective Studies; SARS-CoV-2	2022
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 118 Topics: Antiviral Agents; Azithromycin; Burkina Faso; Chloroquine; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Inpatients; Outpatients; SARS-CoV-2	2022
High-cited favorable studies for COVID-19 treatments ineffective in large trials. Journal of clinical epidemiology, 2022, Volume: 148 Topics: Azithromycin; Colchicine; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Interferons; Lopinavir; Ritonavir	2022
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study. PloS one, 2022, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cephalosporins; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome	2022
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers. Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:4 Topics: Adult; Antimalarials; Azithromycin; Chloroquine; Coronavirus Infections; COVID-19 Drug Treatment; DNA-Binding Proteins; Electrocardiography; Healthy Volunteers; Humans; Hydroxychloroquine; Long QT Syndrome; Pandemics; Pneumonia, Viral; Torsades de Pointes	2022
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia. PloS one, 2022, Volume: 17, Issue:6 Topics: Azithromycin; Calcitriol; Colchicine; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Humans; Hydroxychloroquine; Ivermectin; Pandemics	2022
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency. Cadernos de saude publica, 2022, Volume: 38, Issue:7 Topics: Azithromycin; Brazil; Coronavirus Infections; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral	2022
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic. PloS one, 2022, Volume: 17, Issue:9 Topics: Azithromycin; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Ethnicity; Humans; Hydroxychloroquine; Pandemics; SARS-CoV-2; United States; White People	2022
Application of Secondary Electrospray Ionization Coupled with High-Resolution Mass Spectrometry in Chemical Characterization of Thermally Generated Aerosols. Journal of the American Society for Mass Spectrometry, 2022, Nov-02, Volume: 33, Issue:11 Topics: Aerosols; Azithromycin; Caffeine; Cannabidiol; Hydroxychloroquine; Melatonin; Spectrometry, Mass, Electrospray Ionization; Vitamin B 12	2022
[COVID management at the Regional Hospital of Lambaréné (Gabon) from March 2020 to February 2021]. Medecine tropicale et sante internationale, 2022, 09-30, Volume: 2, Issue:3 Topics: Anti-Bacterial Agents; Azithromycin; COVID-19; Gabon; Hospitals; Humans; Hydroxychloroquine; Oxygen; SARS-CoV-2; Treatment Outcome; Vitamins	2022
COVID-19 pharmaceuticals in aquatic matrices: The threatening effects over cyanobacteria and microalgae. The Science of the total environment, 2023, Sep-20, Volume: 892 Topics: Azithromycin; Chlorella vulgaris; COVID-19; COVID-19 Drug Treatment; Ecosystem; Humans; Hydroxychloroquine; Microalgae; Pharmaceutical Preparations; Water; Water Pollutants, Chemical	2023
Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients. Medicina (Kaunas, Lithuania), 2023, Apr-29, Volume: 59, Issue:5 Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Middle Aged; SARS-CoV-2	2023
Trends in COVID-19-Related Medication Use in US Nursing Homes, 2018-2022. Journal of the American Medical Directors Association, 2023, Volume: 24, Issue:8 Topics: Azithromycin; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Nursing Homes; Retrospective Studies; United States	2023
Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020. Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:12 Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Morocco; Pharmacovigilance	2023
HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk. Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2716 Topics: Action Potentials; Animals; Azithromycin; Electrocardiography; Female; Heart; Humans; Hydroxychloroquine; Male; Swine	2024
Simultaneous LC-MS/MS method for the quantitation of Azithromycin, Hydroxychloroquine and its metabolites in SARS-CoV-2(-/ +) populations using dried blood spots. Scientific reports, 2023, 09-30, Volume: 13, Issue:1 Topics: Azithromycin; Chromatography, Liquid; Communicable Disease Control; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2; Tandem Mass Spectrometry	2023
Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil. Arquivos brasileiros de cardiologia, 2023, Volume: 120, Issue:9 Topics: Aged; Arrhythmias, Cardiac; Azithromycin; Brazil; Chloroquine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2	2023
[Surfactant protein C dysfunction in pediatric patients: Clinical Case]. Andes pediatrica : revista Chilena de pediatria, 2022, Volume: 93, Issue:5 Topics: Azithromycin; Child; Humans; Hydroxychloroquine; Protein C; Pulmonary Surfactant-Associated Protein C; Surface-Active Agents	2022